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A Ab bs st tr ra ac ct t   
Arthritogenic  alphaviruses,  such  as  Ross  River  virus  (RRV)  are  associated  with 
worldwide outbreaks of human polyarthritis/arthralgia.  The pathogenesis of RRV and 
other alphaviruses is poorly understood. Studies have shown potential links between the 
different strains of RRV and variation in their pathogenesis and virulence.  Currently 
there is believed to be two circulating strains of RRV, the south western (SW) from the 
south west region of Western Australia and the north eastern (NE) from the east coast of 
Australia. Studies have suggested that the persistence of RRV may be the result of an 
impaired immune response. This study was designed to determine if the SW and NE 
isolates of RRV have the ability to induce apoptosis in DCs and fibroblasts and discover 
any possible variation in their apoptosis-inducing capacity. Both Vero cells and murine 
bone marrow DCs (BMDCs) were infected with the SW74249 (SW) and SW82627 (NE) 
strains of RRV. A time course analysis of two apoptotic markers and a cell viability 
marker for both cell types was conducted by flow cytometry.  The results indicate RRV- 
induced apoptosis in both Vero cells and BMDCs, with RRV inducing a stronger pro-
apoptotic response in BMDCs than Vero cells, 24 h after infection.  Between the two 
strains there was little variation in the Vero cells over time. In the BMDCs there was 
some variation with the RRV-SW strain inducing a higher percentage of cell death than 
the RRV-NE strain, 24 h after infection.  Collectively, the data indicates that RRV has 
the capacity to induce a pro-apoptotic response in DCs, with the SW presenting as more 
aggressive compared to the NE, potentially leading to greater virulence.  This data could 
help to explain the mechanism of RRV persistence in vertebrate hosts, as well as the 
reported  differences  in  severity  and  duration  of  human  clinical  symptoms.  
Immunotherapy aimed at  correcting the patient’s  dysfunctional  immune system,  may 
represent a new strategy for the successful medical treatment of RRV infection.  iii 
 
A Ac ck kn no ow wl le ed dg gm me en nt ts s   
 
This has been a journey beyond anything I would have expected. This honours project 
saw everything from tears and frustration to happiness and excitement. If it was not for 
the following amazing people, I doubt I would have made it this far. 
 
Firstly to my supervisors, Dr Phil Stumbles, Dr Anthony Armson, Dr Mark Bennett and 
Prof Cassandra Berry, there are no words that could ever truly express my appreciation. 
Through your patience, guidance and experience you have made me a better person and 
scientist. 
 
To Dr Cheryl Johansen and Dr Abbey Potter, thank you for not only the virus isolates, 
but for helping and supporting me during a dire time.  Dr Vanessa Fear, thank you so 
very much for your assistance and support.  
 
In using flow cytometry I was fortunate to be able to call upon Asst Prof Kathy Heel 
and Mrs Tracey Lee-Phullen of CMCA. I discovered their knowledge and assistance is 
second to none,   you have both made me a flow cytometry fan. Thank you for teaching 
me this fantastic skill. 
 
The Murdoch University community is the most helpful and understanding. A huge 
thank you goes to following people who have been amazing. To Dr Kirsty Townsend, 
for helping me work out what I was ordering and allowing me to escape from my lab 
into a teaching one. Dr Emilija Filipovska-Naumovska, Dennis Zienkiewicz and Dean 
Pemberton, you both were so helpful and supportive during some tough times. I will 
miss the midday samples and the laugher that came with them.  To Anti-Fungal team 
member Penny Nice, thank you for all your help, hopefully now the culture lab will 
remain contamination free. Thank you to Dr Andrea Ducki and Dr Tim Hyndman for 
their assistance with the virus cultures. Without you all this project would have finished 
very differently. 
 
To  my  wonderful,  amazing  and  understanding  friends  and  colleagues,  in  particular 
Tanya,  Kaija  and  Narelle,  I  consider  myself  fortunate  to  have  your  support. iv 
 
To my wonderful parents, Tresna and Ron, thank you for being my rock during this 
process with your support and understanding. To my family editors, Todd, Gabby and 
Ron, cheers for reading through this thesis and providing valuable feedback. 
 
Last but not least I would like to finish with a quote by German physicist Max Planck 
 
Anybody who has been seriously engaged in scientific work of any kind realises that 
over the entrance to the gates of the temple of science are written the words: Ye must 
have faith. It is a quality which the scientist cannot dispense with.  
 
 
 
 v 
 
Table of Contents 
 
D DE EC CL LA AR RA AT TI IO ON N .....................................................................................................................  I 
A AB BS ST TR RA AC CT T ............................................................................................................................ II 
A AC CK KN NO OW WL LE ED DG GM ME EN NT TS S ..................................................................................................  III 
TABLE OF CONTENTS  ..................................................................................................... V 
LIST OF FIGURES ........................................................................................................... VII 
LIST OF TABLES ............................................................................................................ VIII 
ABBREVIATIONS ................................................................................................................. IX 
CHAPTER 1: INTRODUCTION  .......................................................................................  1 
1.1 ROSS RIVER VIRUS ........................................................................................................................ 1 
1.1.1 Background  .................................................................................................................................... 1 
1.1.2 Epidemiology ................................................................................................................................ 2 
1.1.3 Molecular Biology ...................................................................................................................... 5 
1.1.3.1 Structure and Genome ........................................................................................... 5 
1.1.3.2 Replication Cycle – Endosomal Pathway ........................................................ 8 
1.1.3.3 Replication Cycle- Antibody Dependent Enhancement ........................... 10 
1.1.4 Ross River virus Disease and Pathogenesis.................................................................... 11 
1.1.4.1 Immune Response to Viral Infection ............................................................. 12 
1.1.4.2 Dendritic Cells ...................................................................................................... 16 
1.1.4.3 Dendritic cells and Viruses ............................................................................... 17 
1.1.4.3 Clinical Symptoms .............................................................................................. 21 
1.1.4.4 Genetic Variation and Virulence ..................................................................... 22 
1.2 APOPTOSIS .................................................................................................................................... 25 
1.2.1 Background  .................................................................................................................................. 25 
1.2.2 Major Pathways ......................................................................................................................... 27 
1.2.2.1 Intrinsic/ Mitochondrial Pathway .................................................................... 27 
1.2.2.2 Extrinsic / Death-Receptors Pathway ............................................................ 29 
1.2.3 Caspases ....................................................................................................................................... 30 
1.3 VIRAL PERSISTENCE AND APOPTOSIS ................................................................................... 33 
1.4 HYPOTHESIS AND AIMS ........................................................................................ 37 
CHAPTER 2: MATERIALS AND METHODS .......................................................... 38 
2.1 CELL CULTURE AND VIRUS ..................................................................................................... 38 
2.1.1 Cell Lines ...................................................................................................................................... 38 
2.1.1.1 Vero Cells .............................................................................................................. 38 
2.1.1.2 Dendritic Cells ...................................................................................................... 38 
2.1.1.3 Subculturing......................................................................................................... 39 
2.1.1.4 Cryopreservation ............................................................................................... 40 
2.1.2 Viral Strains ................................................................................................................................ 40 
2.1.2.1 Viral Inoculation ................................................................................................. 40 
2.2 DETERMINATION OF VIRAL TITRES ....................................................................................... 41 
2.2.1 Fifty Percent Tissue Culture Infectious Dose (TCID50) ............................................. 41 
2.2.2 Temperature Stability ............................................................................................................ 42 
2.3 FLOW CYTOMETRY ANALYSIS ................................................................................................ 42vi 
 
 
2.3.1 Harvesting Method and Apoptosis Induction Optimization ...................................... 42 
2.3.1.1 Harvesting .............................................................................................................. 42 
2.3.1.2 Camptothecin Positive Control Optimization  .............................................. 42 
2.3.2 FLICA and Live/Dead Fixative Viability stain .............................................................. 44 
2.3.3 Cell Staining for Apoptotic Analysis by Flow Cytometry .......................................... 45 
2.3.3.1 Vero Cells .............................................................................................................. 45 
2.3.3.2 Bone Marrow Derived Dendritic cells (BMDCs)....................................... 45 
2.3.3.4 FLICA and Live/Dead staining analysis ....................................................... 46 
2.3.3.5 Annexin V and LIVE/DEAD staining analysis .......................................... 47 
2.4 STATISTICAL ANALYSIS ............................................................................................................ 48 
CHAPTER 3: RESULTS  ................................................................................................... 49 
3.1 CELL CULTURE AND VIRUS STRAINS .................................................................................... 49 
3.2 TCID50 AND INFLUENCE OF STORAGE CONDITIONS .......................................................... 50 
3.4 FLOW CYTOMETRY ANALYSIS ................................................................................................ 51 
3.4.1 BMDC Phenotyping ................................................................................................................. 51 
3.4.2 Optimisation of Vero Cell Harvesting Methods ............................................................ 53 
3.4.3 Optimisation of Camptothecin Concentrations ............................................................. 54 
3.4.4 FLICA and Live/Dead Stain Optimisations..................................................................... 55 
3.4.4.1 FLICA ..................................................................................................................... 55 
3.4.4.2 Live/Dead Viability Stain .................................................................................. 55 
3.4.4.3 Annexin V Stain ................................................................................................... 56 
3.4.5 Analysis of Apoptosis in Vero Cells ................................................................................... 57 
3.4.5.1 FLICA and Live/Dead Stains ........................................................................... 57 
3.4.5.2 Annexin V and Live/Dead Stains .................................................................... 60 
3.4.6 Analysis of Apoptosis in BMDCs ........................................................................................ 63 
3.4.6.1 FLICA and Live/Dead Stains ........................................................................... 63 
3.4.6.2 Annexin V and Live/Dead Stains .................................................................... 66 
CHAPTER 4: DISCUSSION ............................................................................................ 69 
4.1 CELL CULTURE MODELS .......................................................................................................... 69 
4.2 ANALYSIS OF PRELIMINARY APOPTOSIS RESULTS  ............................................................. 71 
4.2.1 Analysis of Apoptosis in Vero Cells ................................................................................... 71 
4.2.2 Analysis of Apoptosis in BMDCs ........................................................................................ 73 
4.3 FUTURE DIRECTIONS ................................................................................................................. 77 
4.3 CONCLUSIONS  .............................................................................................................................. 78 
REFERENCES .................................................................................................................... 79 
 vii 
 
List of Figures 
Figure                      Page 
Figure 1.1. The transmission cycle of RRV....................................................................3 
Figure 1.2 (A) Ross River Virus reconstructed images & cutaway of the multilayer             
    structure...........................................................................................................6    
Figure 1.2 (B) Ross River Virus reconstructed images, a cross-section view.................6 
Figure 1.3 A graphic depiction of RRV genome organisation.........................................7 
Figure 1.4 A simplified life cycle of RRV via Endosome Pathway...............................10 
Figure 1.5 Two proposed mechanisms for viral antibody-dependent enhancement…..11 
Figure 1.6 A depiction of the four stages of apoptosis....................................................26 
Figure 1.7 The Intrinsic Pathway....................................................................................28 
Figure 1.8 The Death Receptor Pathway........................................................................30 
Figure 2.1 FLICA and Live/Dead quadrant set up for apoptosis analysis......................47 
Figure 2.2 Annexin V and Live/Dead quadrant set up for apoptosis analysis................48 
Figure 3.1 Vero cell and RRV-CPE culture...................................................................49 
Figure 3.2 The phenotype analysis of two BMDC cultures after 8 day period..............52 
Figure 3.3 The comparison of Vero harvesting methods................................................53 
Figure 3.4 Comparison ofCPT concentrations on apoptosis induction..........................54 
Figure 3.5 (A) Working concentrations of FITC-conjugated FLICA............................56 
Figure 3.5 (B) Working concentrations of APC-conjugated Live/Dead........................56 
Figure 3.6 RRV-infected Vero cells undergo apoptosis.................................................58 
Figure 3.7 (A) Percentage of late apoptotic cells............................................................59 
Figure 3.7 (B) Percentage of total cell death .................................................................59 
Figure 3.7 (C) Percentage of early apoptotic cells..........................................................59 
Figure 3.8 RRV-infected Vero cells undergo membrane polarity change......................61viii 
 
 
Figure 3.9 (A) Percentage of late apoptotic cells............................................................62 
Figure 3.9 (B) Percentage combined Vero cells death...................................................62 
Figure 3.10 RRV-infected BMDCs undergo cell death.................................................64 
Figure 3.11(A) Percentage of late apoptotic cells...........................................................65 
Figure 3.11 (B) Percentage of combined dead cells.......................................................65 
Figure 3.11 (C) Percentage of non-apoptotic cells.........................................................65 
Figure 3.12 RRV-infected BMDCs undergo membrane polarity change......................67 
Figure 3.13 (A) Percentage of early apoptotic cells.......................................................68 
Figure 3.13 (B) Percentage of late apoptotic cells..........................................................68 
Figure 3.13 (C) Percentage of combined dead cells.......................................................68 
Figure 4.1  The life cycle of dendritic cells (DCs).........................................................76 
 
List of Tables 
Table                      Page 
Table 2.1 Summary of Fluorochromes used...................................................................44 
Table 3.1 Summary of TCID50/mL average values at day 0 and after 7 d storage.........50  
 ix 
 
Abbreviations  
 
ADE        Antibody-dependent enhancement 
APC        Antigen presenting cell 
ATP        Adenosine triphosphate 
Apaf-1       Apoptotic protease-activating factor -1 
AUS $       Australia dollar 
Bak        Bcl2 antagonist/killer 
Bax        Bcl2 associated X protein 
B cell        Bone-marrow derived lymphocyte 
Bcl-2        B-cell leukemia/lymphoma 2 
BMDC        Bone-marrow derived dendritic cell 
CARD       Caspase recruitment domain 
CD        Cadherin domain 
cDNA       Complementary DNA 
CMV        Cytomegalovirus 
CPE        Cytopathic effects 
CPT        Camptothecin 
crmA        Cytokine response modifier A 
DC        Dendritic cell 
DED        Death effector domain 
DMSO       Dimethyl sulfoxide 
DISC        Death-inducing signalling complex 
dsRNA      Double stranded RNA 
DNA        Deoxyribonucleic acid 
DPBS        Dulbecco’s Phosphate-Buffered Saline 
E1-3        E1-3 glycoprotein 
FACS        Fluorescence-activated cell sorting 
FADD       Fas-associated death domain 
FAM        Fluorescein 
FBS        Foetal bovine serum 
FcR        Fc Receptor 
FLICA       Flurorchrome-labeled inhibitors of caspases 
FLICE       FADD-like IL-1β-converting enzyme 
FMK        Fluoro-methyl keton 
GM-CSF      Granulocyte Macrophage Colony-Stimulating Factor 
HIV         Human Immunodeficiency virus 
IAP        Inhibitor of apoptosis 
IFN         Interferon 
IL        Interleukin 
kb        Kilobase 
LCMV       Lymphocytic Choriomeningitis Virus 
LPS        Lipopolysaccharide 
M199        Medium 199 
mAb        Monoclonal antibody 
mDC        Myeloid dendritic cell 
MHC        Major histocompatibility complex 
NE        North-Eastx 
 
 
Nsp        Non-structural protein 
NSW        New South Wales 
NTPase      RNA nucleoside triphosphatases 
PAMPs      Pathogen associated molecular patterns 
pDC        Plasmacytoid dendritic cell 
PRRs        Pathogen recognition receptors 
PS        Phosphatidylserine 
PCR        Polymerase Chain Reaction 
RING        Really interesting new gene 
RNA        Ribonucleic acid 
RRV        Ross River Virus 
RRVD       Ross River Virus Disease 
RT        Room Temperature 
SD        Standard Deviation 
SFV        Semliki Forest Virus 
SINV        Sindbis Virus 
ssRNA       Single stranded RNA 
SW        South-West 
Tc        Cytotoxic T cell 
T cell        Thymus derived lymphocyte 
TCID50      Fifty Percent Tissue Culture Infectious Dose 
Th        Helper T cell 
TLRs        Toll-like receptors 
TNF        Tumour necrosis factor 
TNF-R       Tumour necrosis factor receptor 
TRADD      TNF-R-associated death domain 
Treg        Regulatory T cell 
VAD        Valylalanyl aspartic acid 
vMIA        Viral Mitochondrial Inhibitor of Apoptosis 
UWA        University of Western Australia 
WA         Western Australia 
7-AAD      7-Aminoactinomycin D 
°C        Degrees of Celsius 
%        Percentage 
g        Gravity 
α        Alpha 
β        Beta 
γ         Gamma Page | 1 
Chapter 1: Introduction 
1.1 Ross River Virus 
1.1.1 Background 
The  Togaviridae  family  of  viruses  is  comprised  of  two  genera,  Alphavirus  and 
Rubivirus (Rulli et al. 2005). The Rubivirus genus contains only one virus of human 
importance, the Rubella virus (Martinez and Zapata 2002), while the Alphavirus genus 
contains a group of viruses that are important to humans such as Sindbis Virus (SINV), 
Semliki Forest (SFV) and Ross River Virus (RRV) (Rulli et al. 2007). There are a total 
of 26 known members of the Alphavirus genus based on serological studies that are 
broadly divided into two groups; the New World (American) encephalitis alphaviruses 
and the Old World (Globally distributed) arthritogenic alphaviruses (Rulli et al. 2005; 
Ryman and Klimstra 2008).  These alphaviruses have all been classified as arthropod-
borne viruses (arboviruses) that are transmitted between susceptible vertebrate host and 
a haematophagous arthropod (Russell 2002; Rulli et al. 2005). 
 
Arthritogenic alphaviruses, such as chikungunya virus, o’nyong-nyong virus and Ross 
River virus (RRV) are associated with worldwide outbreaks of human polyarthritis and 
arthralgia.  Alphavirus-induced  diseases  are  generally  not  life-threatening  disease, 
however  they  do  have  a  serious  impact  on  human  health,  with  millions  of  cases 
reported  each  year  (Ryman  and  Klimstra  2008).    Most  recently,  the  re-emerging 
chikungunya  virus  was  responsible  for  an  unprecedented  epidemic  in  a  number  of 
countries  in  the  Indian  Ocean  region.  It  was  the  first  time  that  an  outbreak  was 
associated with some severe clinical signs and lethal cases of encephalitis (Rulli et al. 
2005; Sourisseau et al. 2007; Lidbury et al. 2011).   Page | 2 
 
With  various  aspects  of  alphaviruses  still  unclear  including  their  pathogenesis,  the 
study of this virus for further understanding is becoming extremely important to the 
future  prospects  of  the  discovery  of  specific  treatments  or  a  vaccine  (Bielefeldt-
Ohmann  and  Barclay  1998;  Rulli  et  al.  2005).  This  study  aimed  to  determine  the 
impact of RRV infection on the kinetics of apoptosis in immune and non-immune cell 
types, to give a greater insight into the pathogenesis of the virus. 
 
1.1.2 Epidemiology  
The first possible reports of RRV disease (RRVD) occurred in New South Wales in 
1928 and the virus first was isolated from a pool of Aedes vigilax mosquitoes near the 
Ross River in Queensland in 1959 (Harley et al. 2001; Rulli et al. 2005).  RRVD was 
first originally known as epidemic polyarthritis due to the general arthritis observed in 
infected patients. RRVD was later renamed when the virus was isolated from epidemic 
Polyarthritis patients (Rulli et al. 2005).  RRV is currently endemic in Australia with 
strains  of the virus active annually in all states. RRV is  Australia’s most common 
arbovirus causing up to 8,000 cases annually, costing the community an estimated AUS 
$1,018 per patient per annum, with the costs due to diagnostics and loss in productivity 
(Mylonas et al. 2002; Rulli et al. 2005).   Local epidemics occur in areas including the 
Bunbury region of South-West of Western Australia and the Griffith region of NSW 
(Russell 2002) in association with a range of factors including rainfall and the seasons 
as well as population exposure (Rulli et al. 2005). As an arbovirus, the incidence of 
RRV correlates with the mosquito population. Epidemics have also been recorded in a 
number of Pacific islands including Fiji, Samoa and the Cook Islands (Rulli et al. 2005; 
Rulli et al. 2007).  Page | 3 
 
RRV is primarily sustained in nature by the transmission cycle between mosquitoes and 
susceptible vertebrates (Figure 1.1) (Rulli et al. 2005).  
 
 
Figure 1.1: The transmission cycle of RRV 
The maintenance cycle for RRV in any geographical area will only need to involve a 
single arthropod vector  and a single vertebrate  host, making these viruses  enzootic 
(Rulli et al. 2007). Knowledge about the vertebrate range is limited, with a various 
range  of  mammals  seen  as  possible  hosts.  Non-migratory  native  macropods  are 
believed to be the main vertebrate hosts for RRV (Rulli et al. 2005; Rulli et al. 2007).  
The  virus  has  also  been  isolated  from  other  mammals  including  the  New  Holland 
Mouse and Flying Foxes (Russell 2002; Rulli et al. 2005).  Horses, humans and mice 
are the only hosts of RRV that display clinical signs of infection and are classified as 
incidental hosts and are believed in exceptional circumstances to be involved in the 
maintenance cycle. (Rulli et al. 2005; Rulli et al. 2007).  Horses are suspected to play 
an important part in the transmission of the virus from one area to another but there is a 
still lack of evidence (Rulli et al. 2005).  
 
Horizontal transmission is not believed to be the only form of transmission,  as transfer 
of  the  virus  from  mosquito  to  mosquito  that  can  only  be  explained  by  vertical Page | 4 
transmission,    has  been  observed.  Vertical  transmission  could  explain  how  RRV 
survives between epidemics and over the cooler months (Rulli et al. 2005). 
 
RRV has a complex vector situation compared to other alphaviruses. The virus has 
been  isolated  from  42  mosquito  species  that  span  over  seven  genera:  Ochlerotatus 
(Aedes), Culex, Anopheles, Coquillettidia, Mansonia, Culiseta and Tripteroides (Rulli 
et al. 2005; reviewed in Russell 2002; Ryman and Klimstra 2008).  Although this is a 
broad vector range, only a small number of species have been accepted as significant in 
various regions of Australia. The relative importance of the species also varies with the 
season (Russell 2002; Rulli et al. 2005).  The freshwater species Cx. annulirostris is the 
major vector in inland areas, although a number of other species such as floodwater 
Aedes species and Coquillettidia species are known to carry RRV. Both northern and 
southern salt marsh mosquitoes (Ae. vigilax and Ae. camptorhynchus respectively) are 
the major RRV vectors in coastal areas while Ae. notoscriptus is believed to involved in 
urban areas (Harley et al. 2001; Russell 2002).  
 
Due to different vector species often involved in different environmental regions, the 
epidemiological range is complex with climate and environment influencing the vector 
abundance.  Epidemics, in particular in temperate southern areas, are dependent on the 
summer  and  autumn  rainfall  in  the  inland  areas,  while  the  rainfall  and/or  tidal 
inundations affect the coastal areas (Russell and Dwyer 2000; Russell 2002; Rulli et al. 
2005). 
 
Local  factors  that  increase  the  human-mosquito  exposure  also  influence  the 
epidemiology.    Changes  in  viral  distribution,  increase  in  urbanisation,  changes  in Page | 5 
agricultural practices and the expanding developments of both residential and industrial 
areas in coastal regions are involved in the epidemiology (Rulli et al. 2005).  
 
1.1.3 Molecular Biology 
1.1.3.1 Structure and Genome 
Alphaviruses are a closely related group of enveloped viruses with a single-stranded 
positive sense RNA genome (Strauss and Strauss 1994; Cheng et al. 1995; Rulli et al. 
2005;  Ryman  and  Klimstra  2008).  The  RRV  has  a  11.7kb  genome,  this  can  vary 
slightly between strains (Faragher et al. 1988; Rulli et al. 2005).  
 
The virion expresses two glycosylated proteins: E1 (52kDa) and E2 (49kDa), while a 
third, E3, encoded by the genome, is not expressed (Faragher et al. 1988; Rulli et al. 
2005).  The icosahedral symmetrical nucleocaspid protein C (32kDa), with a diameter 
of 40 nm, is surrounded by a 4.2 nm thick phospholipid bilayer derived from the host. 
At the core of the virion is the genomic RNA (Figure 1.2 A). On the surface of the 
virion, 240 heterodimers of E1 and E2 form 80 trimeric spikes (Strauss and Strauss 
1994; Rulli et al. 2005). In the phospholipid bilayer, these heterodimers associate one-
to-one with the nucleocaspid monomers, as shown in Figure 1.2 B (Cheng et al. 1995; 
Rulli  et  al.  2005).  The  heterodimer  undergoes  irreversible  conformational  changes 
when it is exposed to a acidic fusion pH, triggering the cell/virus fusion (Strauss and 
Strauss  1994;  Bielefeldt-Ohmann  and  Barclay  1998;  Rayner  et  al.  2002;  Wengler 
2009). 
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Figure 1.2: Ross River Virus reconstructed images of (A) a cutaway of the multilayered structure of the 
virion  and  (B)  a  cross-section  view  of  the  overall  organization  within  the  multilayered  structure.  The 
distances from the viral centre are marked on the right. Both diagrams are coloured to represent the different 
viral components; the glycoprotein heterodimer(s) in blue, the phospholipid bilayer in green, the core protein 
in yellow and the RNA-protein interior in red. Å= 0.1 nm. [Figures originally from A) (Strauss and Strauss 
1994) B)  (Cheng et al. 1995) Re-coloured by (Sanders 1999)]. 
 
There are two open reading frames (ORFs) present in the RRV genome, with two-
thirds transcribed from the 5’ end and the other one-third transcribed from the 3’ end of 
the viral RNA (Figure 1.3) (Rayner et al. 2002; Ryman and Klimstra 2008).  The 5’ 
end encodes the non-structural proteins (nsPs) that are involved in the replication and 
synthesis of the genome (Rulli et al. 2005). Each of these proteins has a specific role. 
The  first  nsP  (nsP1)  is  involved  in  binding  and  assembly  of  the  virus  replication 
complex to the intracellular membrane of the host cell. The second nsP (nsP2) is a 
RNA  binding  protein  with  NTPase  and  protease  activity,  whereby  the  nsPs  are 
processed post-translationally. It is speculated that nsP2 functions as a RNA helicase. 
NsP3  is  a  phosphoprotein  while  nsP4  is  believed  to  be    a  polymerase,  based  on 
mutagenesis studies and sequence homology with RNA-dependent RNA polymerases 
(Rayner et al. 2002).  
          A  B Page | 7 
 
 
The structural proteins are encoded from the 26s sub-genomic mRNA that originates 
from the one-third 3’ end genome.  The capsid protein interacts with the RNA genome 
producing  the  nucleocaspid,  while  the  glycoproteins  form  E1,  E2  and  E3  and  the 
hydrophobic peptide-linker 6K protein  (Rayner  et  al. 2002; Rulli  et  al. 2005). The 
capsid protein is autocatalytic and cleaves itself from the polyprotein transcript while 
the  rest  of  the  polyprotein  is  processed  in  the  Endoplasmic  Reticulum  by  cellular 
enzymes  of  the  host.  This  digested  product  is  cleaved  in  the  secretory  vesicles  to 
produce  the  heterodimers  with  the  cleavage  of  the  polyprotein  E2  by  Furin-like 
proteases producing E2 and E3 (Rayner et al. 2002; Ryman and Klimstra 2008).  
 
Each glycoprotein is involved in a specific action in the replication of the virus. E1, the 
haemagglutinin (Burness et al. 1988), plays a part in the fusion with the endosome 
Figure 1.3: A graphic depiction of the Ross River Virus genome organization. The (+) strand 
RNA is used to translate the non-structural proteins (nsP1-4) and a complementary (-) strand. The 
(-) strand is subsequently forms the template for the synthesis of the genomic RNA for new 
progeny and the 26S subgenomic RNA. The 26S RNA is translated into the caspid (C), the 
glycoproteins (E1-E3) and the 6K protein. [Figure from (Bielefeldt-Ohmann and Barclay 1998)] Page | 8 
membrane, while E2 is involved in the attachment of the virus to the host cell receptor 
(Strauss and Strauss 1994; Rayner et al. 2002; Ryman and Klimstra 2008).  E2 has 
been identified to carry a major antigenic site, defined by epitopes a, b1 and b2, for 
antibody neutralization (Burness et al. 1988; Vrati et al. 1988; Rulli et al. 2005). These 
epitopes have been recognised by monoclonal antibodies (mAbs), T10C9, NB3C4 and 
T1E7, respectively (Vrati et al. 1988; Oliveira et al. 1997).  
 
The E2 protein has also been suggested to play a role in RRV virulence. Vrati et al. 
(1986) observed  in mice, a RRV mutant, which carried a 21- nucleotide deletion in the 
E2 gene, appeared asymptomatic compared to wild-type RRV-infected animals.  Vrati 
et al. (1996) also observed that epitope b2 mutant variants of the T48 strain showed 
rapid  penetration;  however  the  growth  kinetics  and  RNA/synthesis  were  impeded 
compared to the T48 parent.  A recent study into viral determinants of alphavirus-
induced rheumatic disease observed that mutations in nsP1 and PE2 play an important 
role in determining RRV-induced musculoskeletal inflammatory disease in a mouse 
model (Jupille et al. 2011).  These studies indicated that the E2 (including PE2) and 
nsP1 proteins play a very important role in RRV   pathogenesis. Virulence, genetic and 
antigenic variation will be discussed later in section 1.1.4.4. 
 
1.1.3.2 Replication Cycle – Endosomal Pathway 
The primary site for RRV replication is skeletal muscle before the virus enters the 
blood stream (Harley et al. 2001). There is believed to be two entry pathways into the 
host  cells;  the  endosomal-based  pathway  (Strauss  and  Strauss  1994;  Sharkey  et  al. 
2001;  Rayner  et  al.  2002;  Ryman  and  Klimstra  2008)  and  the  antibody-dependent Page | 9 
enhancement  (ADE)  pathway  which  is  still  a  relatively  new  concept  (Takada  and 
Kawaoka 2003).  
 
The  endosomal  pathway  is  common  in  the  replication  life  cycles  of  many  viruses 
(Brooks  et  al.  2007)  (Figure  1.4).  When  the  virion  enters  the  host  cell  by  the 
endosomal pathway, the E2 glycoprotein must first attach to an integrin cell surface 
receptor (Harley et al. 2001; Ryman and Klimstra 2008). Studies showing that both C-
type lectins; (DC-SIGN and L-SIGN) (Ryman and Klimstra 2008) and 11 integrin 
receptor (Linn et al. 2005) as possible RRV receptors.  The C-type lectins have been 
observed to bind to the E1-E2 heterodimer complex (Ryman and Klimstra 2008).  Two 
conserved regions in the E2 glycoprotein mimic VI collagen, which the 11 integrin 
has  a  high  affinity  of  binding.  This  would  allow  RRV  to  utilize  these  conserved 
sequences to bind to the 11 integrin as a receptor to enter mammalian cells (Linn et 
al. 2005). Human Immunodeficiency virus (HIV) vectors that express RRV envelope 
glycoproteins have been observed to infect cells from different species however some 
cells could not be infected, suggesting that the host receptors may be limited or absent 
on certain cell types (Strang et al. 2005).   
 
Once attachment has occurred, the virion is enclosed into an endosome (Strauss and 
Strauss 1994; Rayner et al. 2002; Ryman and Klimstra 2008).  Within the endosome, 
the acidity increases as a defence mechanism causing conformational changes in the 
E1-E2  heterodimer  spikes  (Rayner  et  al.  2002;  Ryman  and  Klimstra  2008).    The 
irreversibly changed E1 allows for the virion to fuse with the endosome’s membrane, 
allowing the virus to uncoat and release the nucleocaspid into the cytoplasm unharmed 
(Strauss and Strauss 1994; Harley et al. 2001).  Page | 10 
The viral RNA genome is replicated and transcribed by the host cell’s mechanisms.  
The new synthesized RNA and caspid protein are assembled together producing the 
nucleocaspid of the progeny virus (Rayner et al. 2002; Ryman and Klimstra 2008). The 
nucleocaspid migrates to the area of the host’s cell membrane where the interaction 
between the cytoplasmic domain of the glycoproteins and membrane is occurring. The 
new mature progeny are complete once they bud from the membrane (Rayner et al. 
2002).  
 
Figure 1.4: The simplified life cycle of RRV via Endosome Pathway (Kightley 2005). 
 
1.1.3.3 Replication Cycle- Antibody Dependent Enhancement  
Antibody-dependent enhancement (ADE) activity has been observed in a number of 
different viruses including HIV, Dengue fever virus, Influenza and some alphaviruses 
(Lidbury and Mahalingam 2000). ADE is a process where at low concentrations or sub-
neutralizing levels, antibodies enhance viral infection by attaching to the Fc receptors 
(FcR) resulting in entry via endocytosis (Mahalingam and Lidbury 2002; Takada and 
Kawaoka 2003; Rulli et al. 2005) (Figure 1.5 A).  This is dependent on the cross-
linking of complexes  of virus/antibody through interactions  with  cellular molecules 
(Takada and Kawaoka 2003).   Page | 11 
 
 
 
 
The most common form of ADE is FcR-dependent when the Fc portion of the antibody 
of  the  antibody/virus  complex  attaches  to  the  Fc-  receptor  of  phagocytic  cells 
including macrophages and monocytes (Lidbury and Mahalingam 2000; Takada and 
Kawaoka 2003).  Two concepts of ADE have been observed for RRV-ADE, 1) the 
entry  through  the  attachment  of  the  virus/antibody  complex  to  the  FcR  and  the 
involvement of a secondary co-receptor and 2) the primary FcR to catalyse membrane 
fusion (Takada and Kawaoka 2003) (Figure 1.5 B).   
 
Linn et al (1996) reported the first occurrence of RRV-ADE in macrophages, which 
has  since  led  to  a  number  of  significant  findings  including  the  ability  of  RRV  to 
suppress  or  disrupt  the  antiviral  responses  of  the  innate  immune  system  via  ADE 
pathway (Mahalingam and Lidbury 2002; Suhrbier and La Linn 2003).  
 
1.1.4 Ross River virus Disease and Pathogenesis 
The pathogenesis of alphaviruses is poorly understood, in particular 
alphavirus-induced  arthritides  (Franssila  and  Hedman  2006)  and  persistence  of  the 
virus (Way et al. 2002).  Small animal models are used to understand the pathogenesis 
                              
Figure 1.5: Two proposed mechanisms for viral antibody-dependent enhancement (ADE). (A) The 
interaction between antibody and the FcR. (B) The replication of a virus via ADE entry, leading to the 
suppression of antiviral gene response of the host cell. (Figures from (Takada and Kawaoka 2003) 
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of alphaviruses. Whilst, the majority of models focus on virus-induced neurological 
disease (Rulli et al. 2005), relatively little is known about virus-induced arthritides and 
persistence (Rulli et al. 2005; Franssila and Hedman 2006).  The incubation period of 
the virus generally occurs for 7- 9 days, however it can vary from 3-21 days (Harley et 
al. 2001; Franssila and Hedman 2006; Barber et al. 2009).  
 
Relevant  RRV  infection  mice  models  are  used  to  understanding  the  associated 
pathophysiology  and the mechanisms  that contribute to  immunity  and pathogenesis 
(Griffin 2001; Rulli et al. 2005). Although these RRV mouse models are used, there are 
no  known  models  that are  100%  relevant  to  the  natural  pathogenesis  of  old  world 
alphaviruses (Bielefeldt-Ohmann and Barclay 1998; Ryman and Klimstra 2008).   
 
It is hypothesised that persistence may be the result of ineffectual clearance by poor or 
impaired immune responses, in particular the cell-mediated response (Linn et al. 1998; 
Rulli et al. 2005; Rulli et al. 2007). There are a number of viruses that are associated 
with  a  dysfunctional  immune  system  resulting  in  persistence.  Measles  (Linn  et  al. 
1998), strains of Lymphocytic Choriomeningitis Virus (LCMV) (Carbone and Heath 
2003), Cytomegalovirus (CMV)(Andrews et al. 2001) and HIV (Knight and Patterson 
1997; Whitton and Oldstone 2001) are some of the well known viruses that impair the 
immune system by targeting immune cells, in particular dendritic cells (Vidalain et al. 
2001).  
 
1.1.4.1 Immune Response to Viral Infection  
The mammalian immune response comprises an array of protective mechanisms that 
aim to eliminate invading pathogens from the host. These protective mechanisms are Page | 13 
divided  into  two  major  branches,  the  non-antigen  specific  innate  and  the  antigen-
specific adaptive system (Chaplin 2006).  
 
Rapid developing innate responses recognises conserved microbial components termed 
pathogen  associated  molecular  patterns  (PAMPs)  such  as  dsRNA,  ssRNA, 
lipopolysaccharide (LPS), and unmethylated  CpG-DNA  (Ploegh 1998;  Whitton  and 
Oldstone 2001; Barton and Medzhitov 2002; Chaplin 2006; Cunningham et al. 2010). 
The  components  of  the  innate  response  include  Natural  Killer  cells,  macrophages, 
dendritic cells, neutrophils, various cytokines (interferon (IFN), tumour necrosis factor 
(TNF), interleukin (IL)) and complement (Whitton and Oldstone 2001; Wood 2006). 
This response is an initial response to infection that subsequently primes the adaptive 
response if the infection continues to persist (Ploegh 1998; Palucka and Banchereau 
1999; Turvey and Broide 2010).  
 
Consisting  of  both  humoral  and  cellular  elements,  the  slower  developing  adaptive 
response is mediated by T and B lymphocytes which recognise specific antigen motifs 
or epitopes  of a pathogen by their cell surface receptors.  Antibodies  mainly  act  to 
neutralize the infectivity of free virus by binding to the glycoproteins that interact with 
the  host  cell  receptors,  preventing  attachment  (Ploegh  1998;  Whitton  and  Oldstone 
2001; Wood 2006). Virus-specific antibodies may also agglutinate multiple virions into 
a group reducing infectivity or enhance antibody-dependant cell-mediated cytotoxicity 
(Whitton and Oldstone 2001; Wood 2006).    
 
T cells recognise and often kill infected cells before virus can replicate, reducing the 
release of infectious virions. The major subtypes in the immune response to viruses are Page | 14 
the CD4+ T helper (Th1/Th2/Th17) and CD8+ cytotoxic T cells (Tc). CD8+ T cells 
produce antiviral cytokines (IFN- and TNF-); induce apoptosis in infected cells by 
the  Fas-  ligand  pathway  or  by  granule  exocytosis.  CD4+  T  cells  assist  in  B  cell 
maturation,  antibody  isotype  switching  and  direct  the  adaptive  response  through 
cytokine secretion (Whitton and Oldstone 2001; Wood 2006). Th1 cells support cell-
mediated response through the release of IFN-γ, while Th2 cells support humoral, anti-
helminthic  and  allergic  responses  through  the  release  of  IL-4,  IL-5  and  IL-13. 
Regulatory T cells (Treg) are another class of CD4+ T cells that   mediate immune 
regulation  through  the  release  of  inhibitory  signals  such  as  IL-10  (Barton  and 
Medzhitov 2002; Kopp and Medzhitov 2003; Chaplin 2006). Th17 cells support pro-
inflammation response, through the release of IL-17 however appears to be involved in 
the protection in pathogens (Hou et al. 2009).  
 
The major histocompatibility complex (MHC) proteins help in directing the type of 
immune response through the presentation of processed peptides to T cells, MHC I 
(endogenous pathogens) is expressed by all nucleated cells, while MHC II (exogenous 
pathogens)  is  only  expressed  by  specialized  antigen  presenting  cells  (APCs).  The 
specificity of the MHC class/peptide complex recognized by a T cell receptor and the T 
cell surface marker (CD4 or CD8) allows for T cells to distinguish the source of the 
antigen as either intracellular (e.g. virus) or extracellular (e.g. soluble protein) (Whitton 
and Oldstone 2001; Barton and Medzhitov 2002).  CD8
+ T cells recognise intracellular 
antigens    in  conjunction  with  MHC  I  complexes,  while  CD4
+  T  cells  recognise 
exogenous antigen  in conjunction with MHC II complexes  (Whitton and Oldstone 
2001;  Wood  2006).  An  alternative  pathway  termed  cross-presentation,  whereby Page | 15 
exogenous antigen can access the intracellular MHC Class I processing pathway, has 
also been described (Carbone and Heath 2003).  
 
In RRV infection, the clearance of viraemia is  believed to  principally  mediated by 
antibodies  (Yu  and  Aaskov  1994)  and  type  I  IFN  (α/β)  (Hwang  et  al.  1995). 
Neutralizing antibodies may be important in resolving acute togavirus infection viremia 
however several reports suggest that antibodies are unable to clear residual persistent 
infection.  The  failure  of  neutralizing  antibodies  in  clearance  has  been  observed  in 
human  Rubella  infections  where  arthritis  and  late-onset  Rubella  syndrome  occur 
(Chantler et al. 1985; Verder et al. 1986) and in mouse brains infected with SFV or 
SINV (Hapel 1975; Levine et al. 1994; Amor et al. 1996).  
 
T cell responses are also believed to be significant contributors in the elimination of 
RRV, where reports of CD8
+ T cell activity in mouse models appeared to associate 
with the clearance from the peripheral blood (Linn et al. 1998; Rulli et al. 2005) and 
the predominance of CD4
+ T cells in synovial effusions in chronic RRVD (Linn et al. 
1998; Harley et al. 2001). The predominance of CD4
+ T cells in the serum of chronic 
RRVD patients, as opposed to CD8
+ T cells, could initiate a local non-specific immune 
response,  involving  an  influx  of  mononuclear  cells  instead  of  a  virus-specific  cell 
mediated response. This  suggests that the development  of chronic arthritis  in some 
patients may be due to the inability of the cell-mediated response to completely clear 
infection (Soden et al. 2000; Tupanceska et al. 2007). These cells appear to play a role 
in  determining  if a patient  experiences rapid  recovery or chronic effects  of RRVD 
(Harley et al. 2001). 
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As stated previously, via the ADE pathway, RRV has the ability to negatively impact 
the innate antiviral responses of the host. In RRV-ADE infected macrophages several 
antiviral genes such as TNF- and inducible nitric oxide synthase which have a major 
impact on virus survival are inhibited  (Lidbury and Mahalingam 2000; Takada and 
Kawaoka 2003). Experiments involving LPS induced antiviral activity by Lidbury and 
Mahalingam  (2000),  observed  that  when  ADE  infection  of  macrophages  occurred, 
RRV survived and was able to replicate unrestricted.  Other studies demonstrate an 
increase  in  the  immunosuppressive  cytokine  interleukin-10  (IL-10)  in  RRV-ADE 
infection.    The  ability  of  the  virus  to  inhibit  antiviral  proteins  and  potentially 
manipulate  the  expression  of  others,  allows  the  opportunity  for  enhanced  viral 
pathogenesis and survival (Mahalingam and Lidbury 2002). 
 
1.1.4.2 Dendritic Cells 
Dendritic cells (DC) are specialised immune cells that originate from the bone marrow 
(Whitton and Oldstone 2001). These cells are found throughout the body, distributed 
strategically as sentinels in anatomic sites such as the skin and mucosal surfaces that 
are exposed to antigens and pathogens (Palucka and Banchereau 1999; Whitton and 
Oldstone  2001;  Vermaelen  and  Pauwels  2005). DCs  express  a  variety  of  pathogen 
recognition receptors (PRRs) to enable rapid recognition and binding to PAMPs at the 
initial site including toll-like receptors (TLRs). TLRs are a family of receptors that are 
able to recognise a wide variety of conserved microbial sequences. The expression of 
TLRs has been described in humans and a wide variety of other species (Barton and 
Medzhitov  2002;  Finberg  and  Kurt-Jones  2004;  Chaplin  2006;  Cunningham  et  al. 
2010). DCs consist of plasmacytoid  (pDC) and myeloid (mDC)  subtypes  that have 
common and distinct functions (Palucka 2000; Vermaelen and Pauwels 2005). MDCs Page | 17 
which include Langerhan’s and dermal DCs, stimulate adaptive responses while pDCs 
stimulate the innate response through the production of IFNs (Merad et al. 2008).  
 
DCs found in anatomic sites are termed immature due to their poor ability to stimulate 
naïve T cells. These immature DCs have the capacity to capture and process pathogens 
and antigens and sense their origin and pathogenenicity through TLR binding (Palucka 
and Banchereau 1999; Vermaelen and Pauwels 2005). Following TLR signalling, the 
immature  DCs  undergo  maturation  which  involves  a  number  of  dramatic  changes 
resulting in  the up-regulation of MHC,  co-stimulatory molecules,  the expression of 
cytokines and pro-inflammatory chemokines  (Barton and Medzhitov 2002; Kopp and 
Medzhitov 2003; Vermaelen and Pauwels 2005). This combination enables the DC to 
activate naïve T cells and initiate adaptive immunity. The mature DCs can then migrate 
to the local draining lymph node, where the immune response is regulated through the 
production of cytokines, chemokines and presentation of  processed antigen to T cells 
(Palucka  and  Banchereau  1999;  Vermaelen  and  Pauwels  2005).  Signalling  through 
MHC,  co-stimulatory  molecules  and  TLR  helps  determine  the  nature  of  the  T  cell 
response, for example Th1 (cell-mediated), Th2 (humoral), Th17 (pro-inflammatory) or 
Treg (regulation) (Barton and Medzhitov 2002; Chaplin 2006). Tc activation by DCs 
can occur by endogenous or cross-presentation. DCs can activate the CD8 directly, 
however assistance from Th cells is generally needed (Banchereau et al. 2000). 
 
1.1.4.3 Dendritic cells and Viruses  
Viruses that infect DCs can enhance their pathogenesis by utilising and altering the 
specialized DC functions, by inducing marked changes (e.g. apoptosis) and/ or by more 
widespread,  subtle  changes  (e.g.  altering  cytokine  production)  (Palucka  and Page | 18 
Banchereau 1999; Cunningham et al. 2010). The effects of infection are diverse, with 
viruses  from  the  same  and  different  families  impacting  DCs  differently  by  either 
inhibiting,  stimulating  or  having  no  effect  on  maturation,  antigen  presentation  and 
cytokine/chemokine production (Cunningham et al. 2010).  
 
HIV, measles virus, LCMV and CMV are cell known viruses that utilise DCs in their 
pathogenesis. HIV is believed to use DCs as a transport vehicle for virus dissemination 
and  a  secure  site  for  virus  replication  (Knight  and  Patterson  1997;  Palucka  2000). 
Studies on the impact of HIV infection in DCs have demonstrated that cell death by 
apoptosis and necrosis is induced during the fusion of HIV and pDCs  (Knight and 
Patterson 1997; Meyers et al. 2007).  
 
Measles virus causes immunosuppression by limiting the maturation of DCs (Carbone 
and  Heath  2003;  de  Witte  et  al.  2006),  inhibiting  IL-12  secretion  and  inducing 
apoptosis (Servet-Delprat et al. 2000; de Witte et al. 2006). In co-cultures of DCs and 
T cells in vitro, measles virus-infected DCs fail to stimulate T cell proliferation and 
eventually undergo Fas-mediated apoptosis (Moss et al. 2004; de Witte et al. 2006).  
 
LCMV stimulates the production of IL-10, inhibiting the broad-spectrum response of 
stimulatory cytokine production, T cell proliferation and B cell activation (Kane and 
Golovkina 2010). Studies on LCMV-infected DCs show a poor CD8
+ T cell responses 
and long-term persistence (Sevilla et al. 2000) 
 
Recent studies on CMV infection in DCs showed an impaired capacity of the cells to 
initiate immune responses, suggesting that the primary function was inference with DC Page | 19 
function.  In murine cytomegalovirus infection, DCs showed an impaired capacity to 
completely  prime  T  cells,  with  a  reduced  ability  to  secrete  IL-2.  Infected  DC  also 
showed a down-regulation in surface MHC and co-stimulatory molecules and a mixed 
phenotype of impaired endolytic capacity (Andrews et al. 2001).  
 
In the last few decades the interactions between arboviruses, including alphaviruses and 
DCs have become an increasing focus.  DCs have been observed as primary targets 
early in dengue virus infection (Palucka 2000; Wu et al. 2000; Palmer et al. 2005).  The 
pathogenesis  of  dengue  virus  is  still  elusive,  with  studies  on  dengue  virus-DC 
interactions  demonstrating  the  implications  of  dengue  virus  on  DCs.  Palmer  et  al 
(2005), observed the failure of infected DCs to respond to TNF-α, a maturation stimuli 
producing a less mature phenotype compared to uninfected DCs, leading the cells to 
undergo apoptosis. These infected DCs also produced IL-10 with reduced capacity to 
stimulate  T  cells.  It  is  possible  that  dengue  virus  impairs  the  antigen  presentation 
function by the blockade of maturation and the induction of apoptosis.   
 
Within the alphavirus genus there are known differences in natural cell tropism. An 
example is Venezuelan equine encephalitis being lymphotropic and transducing murine 
DCs  (Gardner  et  al.  2000;  MacDonald  and  Johnston  2000)  while  SFV  is  not 
lymphotropic.  Studies of SINV have shown that variants of this virus differ in their 
ability to infect DCs.  Through these studies it was observed that SINV variants infect 
human and murine DCs differently, suggesting that the receptor expression between the 
DCs differs (Gardner et al. 2000).   Studies by Sourisseau et al (2007) suggested that 
human  DC  infection  by  SINV  vector  is  determined  by  the  substitution  of  a  single 
amino  acid  in  E2.    Studies  on  SINV  mosquito-cell  derived  virions  indicate Page | 20 
preferentially  infection  of  human  mDC,  due  to  the  interaction  between  the  high 
mannose glycans from the virion and the DC-specific DC-SIGN lectin (Shabman et al. 
2007). Mosquito-derived Venezuelan equine encephalitis compared to the mammalian-
derived virus exhibits enhanced infection of murine mDC (Sourisseau et al. 2007).   
 
Shabman  et  al  (2007)  observed  the  interaction  of  mosquito  and  mammalian  cell- 
derived RRV with murine and human mDCs.  They noted that mosquito-cell-derived 
virus had a greater efficiency infecting mDCs yet were a poor inducer of type I IFN 
compared to the mammalian-cell-derived virus, which was a potent inducer of type I 
IFN. These studies suggest the virus when initially delivered by the mosquito vector is 
able to avoid the induction of type I IFN during the initial infection of DCs. Further 
studies observed that N-linked glycans that were present on the E2 glycoprotein of 
mammalian-RRV were required for a robust IFN-α/β induction in mDC cultures. This 
suggests that the mosquito- and mammalian-cell-derived viruses may be directed into 
different compartments within the mDC via differential interactions with mDC surface 
lectin  receptors.  It  may  also  possible  that  the  induction  of  IFN-α/β  could  be 
independent  of  lectin  receptors,  as  the  pattern  recognition  molecule  might  only 
recognise the mammalian-RRV envelope (Shabman et al. 2008).  
 
HIV  vectors  pseudotyped  with  RRV  envelope  glycoproteins  can  infect/transduce 
murine DCs and a number of cell types from different species (Strang et al. 2005; 
Sourisseau  et  al.  2007).  This  HIV-RRV  vector  failed  to  infect/transduce  human 
hematopoietic cells and T cells from human and murine sources (Strang et al. 2005).  It 
appears  that  multiple  parameters  regulate  the  ability  of  alphaviruses  to  infect  and 
impact DCs (Sourisseau et al. 2007).  Page | 21 
1.1.4.3 Clinical Symptoms  
The RRV disease has three major characteristic symptoms; rheumatic symptoms, rash 
and  constitutional  effects  i.e.  fever,  fatigue,  headache  and  myalgia.  The  onset  of 
symptoms occurs suddenly with patients presenting a rash and joint pain (arthralgia) in 
the extremities, a couple of days post-infection. The rash only appears in two-thirds of 
patients (Rulli et al. 2005; Rulli et al. 2007).   
 
The rheumatic joint pain (arthralgia) may occur in a variety of joints with the wrists, 
knees, toes, fingers, ankles and elbows the major sites (Rulli et al. 2005; Barber et al. 
2009). The torsal joints can also be affected.  The arthralgia has a broad manifestation 
range with some patients only having tenderness with minor restriction of movement to 
severe redness and swelling. The rash presents as either maculopapular, vesicular or 
purpuric on the torso and limbs of the patient and generally lasts for 10 days. The rash 
is believed to be the result of cell-mediated response towards viral antigen in the skin 
(Fraser et al. 1983; Rulli et al. 2005). 
 
Although these symptoms are common for the majority, not all patients exhibit every 
symptom. Asymptomatic patients also occur in the population (Barber et al. 2009).    
 There is some discrepancy between studies in terms of the frequency, spectrum and 
recovery  period  of  clinical  RRVD  patients  (Condon  and  Rouse  1995).  Studies  on 
RRVD  from  the  east  coast  show  short  recovery  times  with  little  or  no  persistence 
(Harley  et  al.  2001).  Studies  from  the  south  of  WA  show  that  patients  experience 
longer recovery times with persistence as well as some differences in the spectrum of 
the  symptoms.  Although  an  explanation  for  this  is  still  undetermined,  it  has  been Page | 22 
suggested  that  different  strains  may  vary  in  their  pathogenesis  leading  to  some 
differences in the clinical aspect (Condon and Rouse 1995).  
 
RRV  has  been  observed  to  infect  a  wide  range  of  cell  types  including  fibroblasts, 
skeletal  muscle,  myocytes,  endothelial  cells,  epithelial  cells,  macrophages  and 
monocytes (Linn and Suhrbier 1997; Linn et al. 1998). The large range of cell types 
corresponds  to  the  variety  of  symptoms  that  can  be  present  in  patients. 
Arthralgia/arthritis could result from the infection of synovial fibroblasts, myalgia may 
result from infected myocytes and the rash involves infected epithelial and epidermal 
cells  (Linn  et  al.  1996).  Rheumatism  in  patients  results  from  the  destructive  and 
inflammatory  nature  of  the  viral  cytopathic  effects  and  the  cell-mediated  immune 
response  to  viral  antigen.    Synovial  exudates  from  patients  comprise  monocytes, 
macrophages, B cells, Natural Killer cells and a high number of CD4
+ and CD8
+ T cells 
(Rulli et al. 2007).  This composition is unlike the majority of viral associated arthritis 
as no immune complexes are present and neutrophils are rare, indicating that RRV 
associated arthritis involves a different mechanism (Rulli et al. 2005).   
 
There is currently no treatment shown to reduce the duration or alter the course of 
RRVD. Symptom-based treatments such as physiotherapy and anti-inflammatory drugs 
have been shown to help some patients (Russell and Dwyer 2000; Barber et al. 2009).  
 
1.1.4.4 Genetic Variation and Virulence 
Distinct strains of RRV have been described that vary genetically and antigenically, 
supporting the theory that microevolution in separate geographical areas has occurred 
(Mackenzie  et  al.  1995;  Vrati  et  al.  1996;  Russell  2002).  Isolates  from  different Page | 23 
geographic regions can differ in: virulence levels in both mice and mosquitoes: and 
kinetic haemaggluation and complement fixation tests (Kerr et al. 1992; Lindsay et al. 
1993; Russell 2002). For example, T48 is a mouse virulent strain whereas NB5092, a 
Nelson  Bay,  NSW  isolate,  is  a  mouse  avirulent  strain.  These  strains  can  be 
serologically  distinguished  in  neutralization  tests,  by  T1E7  mAb,  and    show  little 
divergence in sequence at the  amino acid level (Faragher et al. 1988).  
 
RRV studies at the molecular level are inconclusive. Genetic variation of alphaviruses 
is a slow process, as  a new variant must be able to survive and replicate in  both 
vertebrate  and  invertebrate  hosts  (Weaver  et  al.  1992).  Extensive  studies  into  the 
genomic relationship, molecular epidemiology and evolution of RRV were carried out 
by Lindsay et al. (1993) and Sammels et al. (1995).  Lindsay et al. (1993) conducted a 
comparative  analysis  of  80  isolates  from  around  Australia    by  RNase  T1 
oligonucleotide mapping. Results indicated the occurrence of four genotypes  which 
associated with particular geographical regions. These distinct clusters are known as 
topotypes.    The  majority  of  the  isolates  tested  could  be  classified  into  two  major 
circulating  topotypes;  one  from  the  east  and  the  other  from  the  west  of  Australia 
(Mackenzie et al. 1995; Oliveira et al. 1997; Russell 2002).  
 
Sammels  et  al.  (1995)  sequenced  a  505  base  pair  product  from  cloned  or  PCR-
amplified RRV cDNA from the E2/E3 region of 56 isolates. Three genotypes were 
identified from this study.  Genotype I contained only isolates from Queensland prior to 
1967 however all isolates after 1967 are from genotype II. This genotype is believed to 
have originated from the east coast and dominates throughout Australia and the Pacific. 
Isolates from genotype III, have only been found in the South-West of WA (Mackenzie Page | 24 
et al. 1995; Sammels et al. 1995; Smith et al. 2008). Together these two studies both 
concluded the existence of two genotypes that are present in Australia, and based on 
their geographic origin, genotype II is better known as North-East (NE) genotype and 
genotype III is known as South-West (SW).  
 
Prior to 1995, the SW genotype was the predominate genotype in the SWof WA. Since 
1995, the NE genotype has increased in dominance, largely replacing the SW genotype. 
The cause of this shift in dominance still remains unclear (Russell and Dwyer 2000; 
Russell 2002; Smith et al. 2008). 
  
A diagnostic enzyme-linked immunosorbent assay has been developed to allow for an 
antigenic differentiation between the two genotypes using mAb 43B2 which only tests 
positive to the NE isolates. Using a panel of RRV-specific mAbs, including 43B2, 
isolates can be antigenically identified from mosquitoes and other sources (Oliveira et 
al. 1995; Oliveira et al. 1997; Oliveira et al. 2006).  
 
The  involvement  of  genotype  in  pathogenesis  is  still  unknown,  however,  clinical 
surveys from patients has suggested that genotype may have an impact. A study of 
patients  from  the  South-West  by  Condon  and  Rouse  (1995)  found  a  number  of 
differences between the frequency and spectrum of  clinical symptoms, with a longer 
period of recovery compared to studies from elsewhere in Australia. All patients were 
infected during the 1988/89 outbreak in the region. Mouse model studies demonstrated 
differences  between  genotypes  including  the  SW  phenotype,  which  appeared  more 
virulent with a lack of neutralizing antibody production in comparison to the levels 
produced towards the NE phenotype (Prow 2006).  Page | 25 
 
Although there are genetic and antigenic differences present in the RRV population, 
further differentiation may help to  explain the domination of the NE genotype and 
pathogenesis of RRV.  
 
1.2 Apoptosis 
1.2.1 Background 
Programmed cell death, otherwise known as apoptosis, is an essential physiological 
process  involved  in  development,  maintenance  of  homeostasis  and  host  defence  in 
multicellular organisms (Griffin and Hardwick 1997; Chang and Yang 2000; Clayton 
and  Hardwick  2008).  Apoptotic  mechanisms  help  eliminate  potentially  dangerous 
pathogen  -  infected  cells,  such  as  the  auto-reactive  lymphocytes  during  negative 
selection (Griffin and Hardwick 1997; Kumar et al. 2005). Dysfunction of this process 
has implications in a number of diseases including cancer and autoimmune disease 
(Chang and Yang 2000).  
 
Apoptotic  cells  undergo  stage-specific  morphological  changes,  with  correlating 
biochemical  characteristic  (Li  and  Stollar  2004)  (Figure  1.6).  The  first  signs  of 
apoptosis include cytoplasmic and nuclear condensation followed by blebbing of the 
intact  cytoplasmic  membranes.  The  plasma  membrane  loses  polarity,  exposing 
phosphatidylserine (PS). The externalization of PS allows for the binding of Annexin 
V, which can be used for apoptosis  analysis  (Koopman et  al. 1994; Vermes et  al. 
2000). The chromosomal DNA is cleaved by activated endonucleases into nucleosome 
length fragments. The cell shrinks and fragments into membrane-bound bodies, which Page | 26 
Figure  1.6:  A  depiction  of  the  four  stages  of  apoptosis;  stimulation  signal  (1),  the 
intracellular response to stimulus (2), apoptotic changes (3), and phagocytosis or persistence 
of inflammation through cell lysis (4). [Figure from (Afford and Randhawa 2000)] 
contain cytoplasmic and nuclear material, known as apoptotic bodies (Uren and Vaux 
1996; Griffin and Hardwick 1997).  
 
The  apoptotic  bodies  are  engulfed  by  neighbouring  cells  and  tissue  macrophages 
without  mediating  inflammation  (Li  and  Stollar  2004).  Apoptosis  is  different  from 
necrosis  both  biochemically  and  morphologically  (Griffin  and  Hardwick  1997).   
Necrotic cells lose the integrity of their membrane early resulting in the spillage of the 
cytosol  into  the  surrounding  tissue,  mediating  inflammatory  responses  (Griffin  and 
Hardwick 1997; McConkey 1998).  
 
 
 
Apoptosis involves the initiation of different apoptotic pathways; the type of apoptotic 
pathway is being determined by the initiation stimulus.  There are two major pathways; 
the intrinsic or mitochondrial-mediated pathway that is triggered by intracellular events Page | 27 
and the extrinsic or death receptor-mediated pathway that is triggered by extracellular 
events.  An  additional  pathway  is  the  endoplasmic  reticulum  stress  pathway  that  is 
triggered by stress in the endoplasmic reticulum resulting in the release of intracellular 
calcium (Li and Stollar 2004).  
 
1.2.2 Major Pathways 
1.2.2.1 Intrinsic/ Mitochondrial Pathway 
The intrinsic pathway initiators involve any stimuli that occur within the cell such as 
DNA damage caused by UV irradiation and cytotoxic drugs (Kumar et al. 2005).  The 
intracellular  stimulus  activates  Bcl-2  homology  domain-  3  proteins  only  by  post-
transcriptional  means  (Urban  et  al.  2008).    The  activity  of  the  pro-apoptotic  Bcl-2 
family members; Bax and Bak, trigger pores to form in the mitochondrial membrane, 
via  an  unknown  mechanism,  allowing  for  the  release  of  cytochrome  C  and  other 
apoptogenic factors (Irusta et al. 2003; Urban et al. 2008). An apoptosome complex is 
formed by the interactions of dATP/ATP, cytochrome C and the apoptotic protease-
activating  factor-  1(Apaf-1)  and  procaspase  9/caspase  9,  which  are  recruited  by 
cytochrome C, which activates the caspases 3, 6 and 7 (Kumar et al. 2005; Urban et al. 
2008).  These activated caspases lead to the caspase-mediated degradation of protein 
substrates resulting in apoptosis (LeBlanc 2003). 
 
The intrinsic pathway is regulated by members of the Bcl-2 family (Kumar et al. 2005).  
The family consists of proteins that are pro-apoptotic and anti-apoptotic (Griffin and 
Hardwick 1997; Irusta et al. 2003).  The Bcl-2 family proteins play an important role in 
resistance of cells to death. When the anti-apoptotic genes are over expressed or the 
pro-apoptotic genes are down regulated, cells become 'immortal' (Griffin and Hardwick Page | 28 
1997). An example of this is the over expression of Bcl-2 in B cell lymphomas (Griffin 
and Hardwick 1997). Some viruses that are known to cause cell death, are unable to 
induce apoptosis in cells that over express Bcl-2 (Levine et al. 1993). 
 
 
 
 
 
              
 
  Figure 1. 7:  The Intrinsic Pathway. (Figure from (Cell Signaling Technology 2011)) Page | 29 
1.2.2.2 Extrinsic / Death-Receptors Pathway  
The extrinsic pathway is initiated by the binding of receptor specific ligand to the death 
receptors on the cell’s surface.  The TNF gene super family receptors (TNF-R1, TNF-
R2) and Fas/CD95 are the death receptors for mammalian cells and are classified as 
type  1  transmembrane  proteins.  These  receptors  have  cysteine-rich  extracellular 
domains  and  intracellular  cytoplasmic  death  domain,  which  are  essential  for  signal 
transduction and apoptosis to occur (Kumar et al. 2005; Urban et al. 2008). 
 
Stimulation  of  the  death  receptors  initiates  the  formation  of  the  death-inducing 
signalling  complex  (DISC).  In  Fas-mediated  caspase-dependent  apoptosis  the  death 
domain of DISC binds to the death domain of the adapter Fas-associated death domain 
(FADD). The death domain-related death-effector domain (DED) of FADD binds to 
the  DED  present  on  caspase  8,  resulting  in  caspase  8  to  oligomerize  into  DISC.  
Caspase  8  cleaves  caspase  3,  leading  to  the  degradation  of  substrates.  In  TNF-R1 
mediated apoptosis, the death domain of TNF-R1 associates with the death domain of 
the intracellular TNF-R- associated death domain (TRADD) (Clayton and Hardwick 
2008; Urban et al. 2008). 
 
In DISC, TRADD recruits FADD and caspase 8, leading to the cleavage of caspase 3 
(Clayton  and  Hardwick  2008).  The  extrinsic  and  intrinsic  both  converge  at  the 
activation of caspase 3. There is also some cross over between the two, when caspase 8 
mediates cleavage of the Bcl-2 family member Bid into the active truncated Bid (tBid) 
(LeBlanc 2003) Page | 30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2.3 Caspases  
Activated cysteinyl asparate-specific proteases, known as caspases, play a key role as 
the central executioners in apoptosis (LeBlanc 2003). These enzymes cleave cellular 
substrates after an asparate residue, at the carboxyl end, leading to apoptosis (Li and 
Stollar  2004;  Wang  et  al.  2008).  The  caspase  family  members  may  differ  in  their 
primary sequence and substrate specificity, however  members  have several common 
Figure 1.8:  The Death receptor Pathway. (Figure from (Cell Signaling Technology 2011)) 
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features  including that all the caspases are initially synthesised as inactive procaspases 
(zymogens) (Oliver and Vallette 2005).  
 
Caspases, based on the sequence similarity among the protease domains, can be divided 
into three different groups. The first group consists of the inflammatory caspases (1, 4, 
5,11,12,13 and 14), the second group consists of two caspases (2 and 9) and the third 
group consists of the remainder (3, 6, 7, 8 and 10) (Chang and Yang 2000; Fan et al. 
2005) 
   
The caspases are also classified into three groups based on their function; the initiator 
caspases, the effector/executioner caspases and the inflammatory caspases (Grandgirard 
et al. 1998; Fan et al. 2005; Oliver and Vallette 2005).  
 
The  initiator  caspases  (2,  8,  9,  10  and  12)  have  structurally  long  pro-domains  and 
recognisable homolytic protein-protein interaction motifs, including the death effector 
domain  (DED)  and  caspase  recruitment  domain  (CARD),  which  contribute  to  the 
transduction of signals into proteolytic activity (Fan et al. 2005; Oliver and Vallette 
2005).   The initiators are activated first after a cell death initiation signal triggers 
apoptosis (LeBlanc 2003) resulting in proteolytic activity.  The major initiator caspases 
are 8 and 9, that  function through distinct pathways, but culminate in the activation of 
procaspase 3 (Oliver and Vallette 2005).  
 
The effector or executioner caspases (3, 6 and 7) lack intrinsic enzyme activity and 
have short pro-domains (Oliver and Vallette 2005).  These caspases are responsible for 
the irreversible cell damage by cleaving most of the known apoptotic substrates leading Page | 32 
to cell death (LeBlanc 2003; Li and Stollar 2004; Oliver and Vallette 2005). Caspases 
1, 4, 5 and 11-14 are classified as inflammatory mediators and do not appear to play a 
role in apoptosis (Grandgirard et al. 1998; LeBlanc 2003). 
 
Proteases are negatively regulated by different groups of inhibitors, both natural and 
artificial (Ekert et al. 1999; LeBlanc 2003; Wang et al. 2008). Naturally occurring 
inhibitors include viral and cellular genes (Ekert et al. 1999) and can protect the cell 
from caspase-mediated death (LeBlanc 2003). CrmA (cytokine response modifier A), 
from cowpox virus, is a serpin that inhibits caspases directly by targeting the active site 
of mature caspases. This caspase inhibitor is only limited to groups I and III caspases 
(excluding caspase-6). The baculovirus protein, p35, also binds to mature caspases, 
similarly to CrmA.  This inhibitor is a broad-spectrum caspase inhibitor and does not 
inhibit granzyme B. Not all caspase inhibitors bind to the active site, e.g. the IAPs 
(Inhibitors of Apoptosis) (Fan et al. 2005). The mechanisms of these inhibitors are not 
completely understood, however it is thought that caspases may be inhibited through 
direct  interaction  with  the  caspase  or  through  RING-dependent  ubiquitination  and 
proteasomal degradation of the caspases (Chang and Yang 2000; LeBlanc 2003). 
 
Due to their importance in apoptosis, caspases offer an alternative in apoptosis analysis 
compared to gene expression. Apoptosis can be analysed through a variety of different 
methods such as immunoblots using caspase-specific antibodies, immunocytochemical 
identification  of  specific  cleaved  products,  or  by  fluorogenic/chromogenic  caspase 
substrates (Smolewski et al. 2002).   
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For phenotype analysis on a cellular level, instead of a genetic level, flurorchrome-
labeled inhibitors of caspases (FLICA) are used to detect apoptosis. FLICA has three 
distinct  components;  the  flurorochrome  (carboxyfluorescein  or  fluorescein;  FAM) 
domain, the caspase recognition domain (three- or four-amino acid peptide) and the 
covalent  binding  moiety  (chloro-  fluoro-methyl  keton;  FMK).  This  binding  moiety 
binds to the cysteine of activated caspases, producing a thiomethyl ketone, resulting in 
the irreversible inactivation of the enzyme.  FLICA is relatively nontoxic to cells and 
penetrates through the plasma membrane of live cells, binding to activated caspases in 
apoptotic cells. Unbound FLICA is removed from non-apoptotic cells via the washing 
buffer.  The recognition peptide moiety of FLICA provides some level of specificity 
between  ligand  and  particular  caspases.  FAM  -VAD-  FMK,  containing  valylalanyl 
aspartic  acid,  and  are  known  as  a  pan-caspase  markers,  as  the  FLICA  binds  to 
numerous  caspases-  1,3,4,5,7,8  and  9,  allowing  for  the  analysis  of  apoptosis  from 
multiple  markers  (Vermes  et  al.  2000;  Smolewski  et  al.  2002;  Grabarek  and 
Darzynkiewicz 2003).  
 
1.3 Viral Persistence and Apoptosis  
The majority of viruses cause acute, self-limiting infections where the virus replicates 
rapidly then disseminates to a new host before the host clears the infection or dies.  
Some viruses have evolved to establish persistent infections through the manipulation 
of cellular mechanisms of the host in a sophisticated relationship. There are various 
modes of persistence e.g. non-productive, proviral integration, continuous integration 
(Kane and Golovkina 2010). All these modes result in the presence of infectious virus, 
virion  components  (antigen,  protein,  nucleic  acid)  and  virus-specific  antibodies  in 
vertebrates after the initial infection (Kuno 2001).  Page | 34 
Viruses  may  carry  genes  that  either  induce  and/or  prevent  apoptosis.  Inhibitor 
mechanisms can prevent the infected cells from undergoing immune response-induced 
apoptosis, allowing the virus to continue to replicate and infect neighbouring cells.  
Viruses that inhibit apoptosis may express the inhibitor mechanisms that are encoded in 
the genome or induce the expression of the host’s endogenous anti-apoptotic proteins 
(Griffin and Hardwick 1997; Li and Stollar 2004).  
 
The CMV genome contains an IAP termed vMIA (Viral Mitochondrial Inhibitor of 
Apoptosis) (Irusta et al. 2003; Andoniou 2010).  This particular protein can suppress 
apoptosis during infection by blocking the part in the apoptosis pathway where bcl-2 
functions (Irusta et al. 2003). Herpes viruses also inhibit apoptosis by modulating the 
activation of caspase 8. The viral FLICE-inhibitoryprotein binds to the DED of FADD 
(Clayton and Hardwick 2008). The crmA protein of the cowpox and vaccina viruses 
encodes  serine  protease  inhibitors  (serpins)  that  inhibit  both  serine  and  cysterine 
proteases that include caspases 1,8 and 10 (Clayton and Hardwick 2008).   
 
It has been established that persistent viral infections, target immune cells, preventing 
the  clearance  of  the  virus  from  the  host.  Immunosuppression  may  result  from 
deregulation of molecules or dysfunction of the cells, either directly by the virus or 
indirectly through immunopathological mechanisms (Sevilla et al. 2000; Kuno 2001; 
Fahey and Brooks 2010).  HIV’s impact on the immune system is well documented. 
HIV induces apoptosis in CD4+ T cells, leading to a decline in this T cell subset.  
Studies  using  caspase  inhibitors  can  block  HIV-induced  apoptosis  leading  to  cell 
survival. A side effect of this survival is increased viral replication (Chang and Yang 
2000).  Measles is another virus that causes immunosuppression, by inducing apoptosis Page | 35 
in DCs, leading to poor stimulation of T cells (Palucka and Banchereau 1999; Carbone 
and  Heath  2003)  with  impaired  CD8
+  T  cell  activity,  resulting  in  ineffective  virus 
clearance (Carbone and Heath 2003).  
 
It has been suggested, through various studies, that alphaviruses kill cells by inducing 
apoptosis or lytic necrosis (Levine et al. 1993; Strauss and Strauss 1994). Studies have 
shown exceptions to virus-induced death. Appel et al. (2000) observed that SINV can 
either produce a persistent or a lytic infection, depending on the cell type and viral 
strain.   SINV-infected  mature neurons,  which  over express  bcl-2,  have  a persistent 
infection, while infected immature neurons die (Levine et al. 1993). Strains of SINV 
that differ in virulence appear to impact on whether an infection would cause apoptosis 
or persistence.  Appel et al. (2000) observed that non-virulent SINV strains produce a 
non-lytic persistent infection, with an increase in bcl-2 expression. Whereas a virulent 
strain  induced  apoptosis  with  an  increase  in    pro-apoptotic  bax  protein  expression 
levels (Appel et al. 2000). These studies suggest that the differential expression of anti-
apoptotic genes and proteins may be important in determining virulence-specific viral 
persistence (Levine et al. 1993; Appel et al. 2000). 
 
It  is  believed  that  persistent  infections  are  responsible  for  viral  induced  chronic 
arthritides (Linn and Suhrbier 1997; Perl 1999) with symptoms sometimes persisting 
for months (Perl 1999).   This is a clinical feature of RRVD, with symptomatic relapses 
occurring months after the initial onset of infection (Way et al. 2002). The first report 
of persistent RRV infection was by Eaton and Hapel (1976), who observed a prolonged 
non-lytic infection in primary muscle cultures of mice, while Journeaux et al (1987) 
established a prolonged non-lytic infection in synovial cells. These two studies give Page | 36 
some indication that apoptosis may be influenced by RRV, similar to SINV (Eaton and 
Hapel 1976). More recently, a study by Way et al. (2002) into the persistence of RRV 
in macrophages revealed that the infection was capable of persisting up to 170 days. 
This persistence has only been identified in macrophages and not monocytes, but the 
mechanism  has yet to be identified (Linn and Suhrbier 1997).  
 
Cellular  pathways  involved  in  RRV  and  other  alphavirus-regulated  apoptosis  are 
complex  and  poorly  understood  (Li  and  Stollar  2004).  There  are  indications  that 
caspases or the death receptor pathway may be involved (Appel et al. 2000).  Further 
research  into  the  mechanisms  in  different  infected  cell  types  may  enhance  the 
understanding of the pathogenesis of RRV and alphavirus persistence.  
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1.4 Hypothesis and Aims 
The underlying hypothesis of this project is Ross River virus (RRV) isolates will 
induce apoptosis differently in mammalian cell types depending on the origin of the 
cell,  the  time  following  infection  and  the  isolate  of  RRV.  More  specifically,  it  is 
hypothesised  that  cells  co-ordinating  immune  responses  to  RRV  will  be  more 
susceptible to apoptosis induction than non-immune cells that support viral replication.  
 
The overall aim of the project was to examine the kinetics of expression markers of 
cell death and apoptosis by flow cytometry in mammalian cell types of immune and 
non-immune origins following infection with phenotypically distinct isolates of RRV.  
 
Specifically the study aims were as followed:  
1.  Examine the expression of markers of early and late apoptosis in RRV-infected 
fibroblasts (Vero cells). 
2.  Compare the induction of apoptosis in Vero cells infected with North-East (NE) 
and South-West (SW) isolates of RRV. 
3.  Examine the expression of markers of early and late apoptosis in RRV-infected 
bone-marrow derived dendritic cells (BMDC). 
4.  Compare the induction of apoptosis in BMDCs infected with the NE and SW 
isolates of RRV.  Page | 38 
Chapter 2: Materials and Methods 
2.1 Cell Culture and Virus  
2.1.1 Cell Lines 
2.1.1.1 Vero Cells 
 
The anchorage-dependent Vero cells are derived from kidney epithelial cells of an 
African green monkey (Cercopithecus aethiops). An initial supply of Vero cells from 
Dean  Pemberton  (Murdoch  University),  was  cultured  in  Roswell  Park  Memorial 
Institute medium (GIBCO BRL, Eggenstein, Germany) supplemented with 10% heat-
inactivated foetal bovine serum (FBS) (Invitrogen, California USA) L-Glutamine (2 
mM, Sigma-Aldrich), penicillin (100 U/mL, Sigma) and, streptomycin (100 µg/mL, 
Sigma-Aldrich).  
 
The  Arbovirus  surveillance  unit  at  the  University  of  Western  Australia  (UWA) 
supplied  two  batches  of  Vero  cells,    which  were  grown  in  Medium  199  (M199) 
(Sigma-Aldrich, Missouri, USA) supplemented with 5% heat inactivated foetal bovine 
serum  (FBS)  (Invitrogen,  California  USA)  L-Glutamine  (2  mM,  Sigma-Aldrich),  
penicillin (100 U/mL, Sigma) and streptomycin (100 µg/mL, Sigma-Aldrich). All cells 
were incubated at 37C in 5% CO2. 
 
2.1.1.2 Dendritic Cells 
BMDCs  were  prepared  based  on  the  procedure  developed  by  Lutz  et  al  (1999). 
Briefly, femurs and tibiae of 7 week old male BALB/c mice (Telethon Institute for 
Child  Health  Research,  Perth  WA)  were  removed  and  purified  from  surrounding Page | 39 
muscle  tissue.  Intact  bones  were  then  incubated  in  70%  ethanol  for  2-5  min  for 
disinfection  and  washed  with  Dulbecco’s  Phosphate-Buffered  Saline  (DPBS) 
(performed by Dr Vanessa Fear). Both ends were cut and the marrow flushed out with 
PBS using a syringe with a 0.45 mm diameter needle. Vigorous pipetting disintegrated 
clusters with the marrow suspension. 
 
The  flushed  cells  were  plated  in  Iscove’s  Modified  Dulbecco’s  medium  (GIBCO) 
supplemented with gentamycin (50 µg/mL, Sigma), 2-mercaptoethanol (50 µmol/L, 
Sigma),  10%  heat-inactivated  FBS  and  10%  Granulocyte  Macrophage  Colony- 
Stimulating Factor (GM-CSF). 
 
BMDC cultures were phenotyped by Dr Vanessa Fear (Telethon Institute for Child 
Health Research) on day 8 using antibodies which included the following; MHC Class 
II, CD11b, CD11c, CD40 and CD80 and analysed by flow cytometry.  
 
2.1.1.3 Subculturing  
Vero cells were subcultured when the desired confluency (~80%) was reached. The 
growth media was removed and the monolayer was washed with DPBS (Sigma) then 
discarded. An appropriate amount of trypsin (3 – 5 mL) (Cellgro, Virginia USA) was 
added  to  the  monolayer.  The  flask  was  incubated  with  trypsin  to  disrupt  the 
monolayer. Once the monolayer was disrupted, the cells were resuspended with fresh 
growth media and aspirated. The aspirated cell solution was then aliquotted into the 
appropriate number of new flasks. Subculturing was used to routinely maintain the cell 
lines. 
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2.1.1.4 Cryopreservation 
Stocks of Vero cells were maintained by cryopreservation.  The stocks were preserved 
in 1:2 of M199 media and freeze mix which consisted of 15% dimethyl sulfoxide 
(DMSO) (Sigma) and 85% FBS. An isopropanol container was used for freezing the 
cryovials slowly at −80C. The cyrovials were then placed into liquid nitrogen for 
long-term storage. 
 
Resuscitated cells  were  defrosted quickly in  a  37C water bath  and  centrifuged  at 
20 1× g for 5 min. The supernatant was discarded and the cells were resuspended in 
fresh growth media. The resuspended cells were placed into a new flask and incubated 
at 37C with 5% CO2.  
 
2.1.2 Viral Strains 
The  RRV  strains  used  were  SW21012,  SW74249  (SW  genotype),  SW82627  and 
DC39810, (NE genotypes), originally isolated from the Peel Region of W.A. These 
were provided by the Arbovirology Surveillance Unit at the University of Western 
Australia. Each viral strain was isolated from the supernatant of infected Vero cells 
once the monolayer exhibited over 70% cytopathic effect (CPE). The supernatant was 
collected, centrifuged at 450 × g for 10 min at 4C then aliquotted and stored at −80 
until further use.  
 
2.1.2.1 Viral Inoculation 
Vero cells were grown to 90-100% confluency and inoculated with a strain of RRV, 
either SW74249 (SW genotype) or SW82627 (NE genotypes). Non-inoculated control Page | 41 
flasks were also maintained for comparison. Growth media was aspirated and replaced 
with M199 media (2 mL) supplemented with 2% FBS. RRV diluted in M199 solution 
(50 µL) was added to the flask. To maximize absorption, cells were incubated at 37C 
in 5% CO2 for 1 h, with gentle swirling of the flask every 10 min. After 1 h, the 
volume of the media was increased to 10 mL. The flasks were incubated at 37C in 5% 
CO2, until 70 – 80% CPE was observed. Virus containing supernatant was harvested 
and stored until further use as described above (Section 2.1.2). 
 
2.2 Determination of Viral Titres 
Plaque assays were attempted originally to determine viral titre, however they were not 
able to be optimised in the time frame and another alterative was used.   
 
2.2.1 Fifty Percent Tissue Culture Infectious Dose (TCID50) 
Stocks  of  the  two  genotypes  of  RRV  were  titrated  by  fifty  percent  tissue  culture 
infective dose (TCID50) assay. Confluent monolayers of Vero cells were grown in 48 
well  plates  (Greiner  bio-one,  Germany),  spent  medium  was  removed  and  the 
monolayers  inoculated  with  200  µL/  well  of  10-fold  serial  dilutions  (10
-2 ‒10
-7)  of 
RRV. Cell controls were inoculated with 2% FBS M199 without virus. The plates were 
incubated at 37C and 5% CO2 for an h to allow viral attachment after which 200 µL of 
media was added. Plates were checked daily for signs of CPE, with the wells marked 
+/- CPE, until around 5 days. The TCID50 was calculated using the Reed and Muench 
method (Reed and Muench 1938). Page | 42 
2.2.2 Temperature Stability 
To test the stability of RRV at 4C for a 7 d period, TCID50 assays were prepared 
before and after storage. The values were compared to determine if the temperature had 
a significant impact. Both SW74249 and SW82627 RRV isolates were tested.  
 
2.3 Flow Cytometry Analysis  
2.3.1 Harvesting Method and Apoptosis Induction Optimization  
2.3.1.1 Harvesting  
Confluent  Vero  cells  were  harvested  by  different  techniques  to  optimise  flow 
cytometry  results.    Cells  were  harvested  by  cell  scrapping  or  trypsin.    Cells  were 
harvested  by  cell  scraper  (Becton  Dickinson,  New  Jersey,  USA)  in  PBS  (2  mL), 
containing 5% FBS and EDTA (1 mmol/L). Trypsinized cells were harvested by the 
standard  cell  subculturing  method  (Section  2.1.1.2).  All  harvested  cells  were 
centrifuged  (201  ×  g,  5  min)  and  re-suspended  in  PBS  containing  5%  FBS,  to  a 
concentration  of  ~10
6  cells/mL.  A  volume  of  500L  of  each  cell  suspension  was 
filtered  through  38  m  nylon  mesh  (Supplied  by  Centre  for  Microscopy, 
Characterisation  and  Analysis,  UWA)  into  5  mL  polystyrene  12  x  75  mm  Falcon 
FACS tubes (Becton Dickinson). The forward and side scatter of the samples was 
measured by the BD FACSCantoII system (Becton Dickinson).  
 
2.3.1.2 Camptothecin Positive Control Optimization 
First, the optimisation of an apoptotic inducer was performed to serve as a positive 
control.  The DNA topoisomerase I inhibitor camptothecin (CPT) (Sigma-Aldrich) was 
tested on different controls and analysed by PE Annexin V Apoptosis Detection Kit I Page | 43 
(Becton  Dickinson),  following  a  slightly  modified  manufacturers’  protocol  to 
accommodate the adherent Vero cells.  
 
Briefly, Vero cells were grown to 80-100% confluency and treated with three different 
concentrations of CPT: 1 µ mol/L (Hofmann et al. 1999), 5  mol/L and 14.5 µ mol/L 
(Brown et al. 2009) for 24 h. Non-treated cells were prepared for a comparison control. 
Cells exposed to 14.5 µ mol/L CPT or liquid nitrogen served as separate single stained 
positive  controls.  Samples  were  washed  twice  in  serum-free  PBS  and  collected  by 
tryprsinization.  Cells were then re-suspended to a concentration of ~10
6 cells/mL, with 
1 X Annexin V Binding Buffer (10X buffer: 0.1 mol/L Hepes/NaOH (pH 7.4), 1.4 
mol/L NaCl, 25 m mol/L CaCl2) (Becton Dickinson). Cells (100 L) were transferred 
to an individual flow cytometry tube (Becton  Dickinson) through nylon mesh.  PE 
Annexin V (5 µL) and/or 7-Amino-Actinomycin (7-ADD) (5 µL) were added to the 
required samples. Non-treated cells were not stained.  Samples were gently vortexed 
then incubated at RT in the dark for 15 min. After incubation, 1 X Annexin V Binding 
Buffer (400 L) was added to each sample. Cell fluorescence was measured within 1 h 
by the FACSCanto II flow cytometer, using standard emission filters (Table 2.1). Page | 44 
 
 Table 2.1. Summary of Fluorochromes used 
Fluorochrome  Fluorescence 
Emission Colour 
Ex-
Max(nm) 
Excitation Laser 
Line (nm) 
Em-
Max(nm) 
FITC **  Green  494  488  519 
FAM- FLICA  Green    488  530 
Annexin V PE*/**  Yellow  469, 564  488, 532, 561  578 
7AAD*  Red  543  488, 532, 561  647 
APC **  Red  650  633,635, 640  660 
Far Red Live/Dead  Red  650  633,635  665 
 
Fluorochrome parameters used in Annexin V/ 7-ADD analysis (*); Fluorochrome parameters 
used in FLICA/ Live/Dead/ Annexin V analysis (**).   
 
2.3.2 FLICA and Live/Dead Fixative Viability stain 
FAM-VAD-FMK poly-caspase reagent was obtained from Invitrogen. This inhibitor, as 
a  component  of  the  Vybrant  FAM  Poly  Caspases  Assay  Kit  (FLICA)  (Molecular 
Probes, Oregon USA), was dissolved in DMSO as specified by the manufacture to 
obtain  150X  concentrated  (stock)  solution.  Aliquots  of  this  solution  were  stored 
at −20C, while protected from light. Working solution was prepared by diluting the 
stock solution in PBS and protected from light.  
 
As  virus-infected  cells  were  required  to  be  fixed  before  flow  cytometry,  a  plasma 
membrane permeability stain was required that could be used with paraformaldehyde 
fixed cells. The live/dead powder from the LIVE/DEAD Fixable Dead Cell stain kit 
(Molecular Probes) was dissolved in DMSO as specified by the manufacturer to obtain 
a reconstituted form. The dye was stored at −20C, while protected from light.  
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2.3.3 Cell Staining for Apoptotic Analysis by Flow Cytometry 
2.3.3.1 Vero Cells 
Vero cells were grown to 90 - 100% confluency and inoculated with a strain of RRV, 
14.5 µ mol/L CPT or mock infected. Both SW74249 and SW82627 strains were used. 
Old growth media was discarded and replaced with 2 mL of M199 media supplemented 
with  2%  FBS..  To  reduce  the  influence  of  virus  concentration,  the  stocks  were 
equalized by dilution using M199 based from TCID50 assay results.  100 µL of RRV-
containing solution was added to the respective flasks. All flasks were incubated under 
the same conditions as viral inoculations (Section 2.1.2.1). At 8, 24, 48 and 72 h, one 
flask for each experimental condition was removed and stained for  flow cytometry 
analysis using three dyes; FLICA, Live/Dead and Annexin V. Cell culture supernatant 
was collect and washed with serum-free DPBS, which was also collected. Cultures 
were harvested by trypsinization then centrifuged with collected supernatant (290 x g, 
10 min).  
 
Supernatant  was  removed  after  centrifugation  and  the  cells  were  re-suspended  in 
serum-free DPBS to a cell concentration of ~1-2 x 10
6 cells/mL.  All staining followed 
slightly modified manufacturers’ protocols as stated below (Section 2.5 and 2.6).  A 
number  of  controls  were  produced  with  each  staining  group;  unstained,  and  single 
stained samples.  
 
2.3.3.2 Bone Marrow Derived Dendritic cells (BMDCs) 
BMDCs were inoculated (100 L) with a strain of RRV or mock infected.  Viruses 
were adjusted to equal concentrations determined by TCID50 assay.  At 24 and 48 h, Page | 46 
cells were stained for FACS analysis using FLICA, Live/Dead and Annexin V.  The 
growth media was collected and the plates were washed in DPBS. The collected cells 
were centrifuged (290 x g, 10 min) and the supernatant was removed. Cells were re-
suspended in 1.5 mL DPBS. 
 
Again, all staining followed slightly modified manufacturers’ protocols as stated below.  
A number of controls were produced with each staining group; unstained, and single 
stained samples. 
 
2.3.3.4 FLICA and Live/Dead staining analysis 
For each test sample, 300 L of cell suspension was transferred to individual 5 mL 
polystyrene  12  x  75  mm  Falcon  FACS  tube.  To  the  required  test  tubes  10  L  of 
working solution of FAM-VAD-FMK (FLICA) were added to suspensions. The cells 
were protected from light and incubated for 1 h at 37C with 5% CO2 with gentle 
mixing every 20mins. The cells  were washed and centrifuged twice, once with 1X 
Apoptosis wash buffer (supplied in the FAM Kit) and once with cold DPBS.  
 
Samples to be stained with the Live/Dead stain (Molecular Probes) were re-suspended 
in 500 L cold DPBS. After adding 0.1 L of reconstituted Live/Dead dye, the cell 
suspensions  were  protected  from  light  and  incubated  at  RT  for  30  min.  All  cell 
suspensions were washed, centrifuged and then re-suspended in ~500 L of DPBS. 
Due to biological restrictions of RRV, all samples were fixed by adding 1:10 of fixative 
solution, 10% formaldehyde solution (supplied in FAM-FLICA kit), and incubated for 
15  min  at  RT.  All  samples  were  analysed  on  the  FACSCanto  II,  using  standard Page | 47 
emission filters (Table 2.1), within 24 h post-fixation. Gating for analysis was set up 
was for all samples as present in Figure 2.1. 
 
                              
 
 
 
 
2.3.3.5 Annexin V and LIVE/DEAD staining analysis 
For each test sample, 300 L of cell suspension was transferred to individual 5 mL 
polystyrene 12 x 75 mm Falcon FACS tubes and then increased to 500 L with DPBS. 
After adding 0.1 L of reconstituted Live/Dead dye, the cell suspensions were protected 
from  light  and  incubated  at  RT  for  30  min.    All  stained  samples  were  washed, 
centrifuged and then re-suspended.  
 
The samples to be stained with Annexin V were re-suspended in 100 L 1X Annexin V 
Binding Buffer.  5 L of Annexin V was added to samples then gently vortexed and 
protected from light.  After 20 min incubation, 400  L of 1X Binding Buffer was 
Figure 2.1. FLICA and Live/Dead quadrant set up for apoptosis analysis. 
FLICA–negative, Live/Dead-weak represents non-apoptotic cells. FLICA–positive, Live/Dead 
–weak  represents  early  apoptotic  cells.  FLICA–positive,  Live/Dead–strong  represents  late 
apoptotic cells. FLICA–negative, Live/Dead–strong represents necrotic/ non-apoptotic dead 
cells  
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added.  Due to biological restrictions of RRV, all samples were fixed using 1:10 of 
fixative  solution.  All  samples  were  analysed  on  the  FACSCanto  II,  using  standard 
emission filters (Table 2.1), within 24 h post fixation. Gating for analysis was set up 
was for all samples as present in Figure 2.2. 
 
                            
 
 
 
 
2.4 Statistical Analysis 
 
Differences in the TCID50 results were assessed statistically using a Student’s t test at a 
significant level of 0.05. The analysis was completed in SPSS.  
 
 
Figure 2.2. Annexin V and Live/Dead quadrant set up for apoptosis analysis. 
Annexin V–negative, Live/Dead -weak represents non-apoptotic cells. Annexin V–positive, 
Live/Dead –weak represents early apoptotic  cells. Annexin V–positive, Live/Dead –strong 
represents late apoptotic cells. Annexin V–negative, Live/Dead –strong represents necrotic/ 
non-apoptotic dead cells  Page | 49 
Chapter 3: Results 
3.1 Cell Culture and Virus Strains  
For the in vitro propagation of RRV, Vero cells were inoculated with RRV once the 
cells had grown to 90 – 100% confluence (Figure 3.1 A). Uninoculated control flasks 
were maintained for comparison. Virus inoculated cultures were harvested once the 
cytopathetic effects (CPE) (detachment and rounding of cells from the monolayer and 
clumping) reached 70 – 90% (Figure 3.1 B). Initial infections with Vero cells failed to 
present CPE. Reasons for the failure were unknown and Vero stocks were replaced 
with Vero cells that were known to be susceptible to CPE infection from the Arbovirus 
Surveillance Centre. 
       
Figure 3.1: Vero cell and RRV – CPE culture. (A) 100% confluent Vero cells and (B) 
RRV infected Vero cells. (Bar =10µm). 
 
 
Four  RRV  isolates  were  used;  SW21012,  SW74249,  SW82627  and  DC39810. 
SW21012 and SW74249 showed CPE 2 to 3 d post-inoculation while SW82627 and 
DC39810 showed CPE 5-7 d post-inoculation. Due to a lack of monoclonal antibody 
typing  of  SW21012;  isolates  SW74249  and  SW82627  were  chosen  for 
experimentation.  These  isolates  had  been  phenotyped  using  monoclonal  antibody 
typing tests as south-west (RRV-SW) and north-east (RRV-NE) respectively by the 
Arbovirus Surveillance Lab (UWA).   
A  B Page | 50 
3.2 TCID50 and Influence of Storage Conditions 
TCID50 assays were used to ensure similar viral titres of RRV isolates were inoculated 
into cell cultures for subsequent experiments.  To determine whether storage at 4°C for 
7 d had a significant impact on the viral titre, TCID50 assays were performed on batches 
of SW82627 and SW74249 at day 0 and after 7 d of storage at 4°C. Table 3.1 shows a 
summary of the average TCID50/mL values. The statistical paired t-test comparison 
between the infectious titres of the isolates before and after storage at 4°C for 7 d 
resulted in insignificant p-values = 0.952 (RRV-SW) and 0.089 (RRV-NE). Storage for 
7 d at 4°C did not appear to have a statistically significant influence on the viral titre. 
 
Table 3.1 - Summary of TCID50/mL average values at day 0 (A) and after 7 d 
storage 4°C (B) (n = 4 per strain) 
Isolate ID  Average TCID50/mL ± SD  Average log value ± SD 
RRV-NE (A)  4.82 × 10
6± 4.47 ×10
6  10
6.7±10
6.65 
RRV-NE (B)  3.61 × 10
6± 4.44 ×10
6  10
6.6±10
6.64 
RRV-SW (A)  9.40 × 10
5± 5.98 ×10
5  10
6±10
5.7 
RRV-SW (B)  9.04 × 10
5± 1.13 ×10
6  10
6±10
6.05 
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3.4 Flow Cytometry Analysis 
3.4.1 BMDC Phenotyping 
Two BMDC cultures were phenotyped for surface expression by Dr Vanessa Fear; one 
was stimulated 1 µg LPS (right) to show they can be activated via TLR4, the other 
unstimulated (left). Cultures were assessed by flow cytometry for viable CD11c and 
MHC class II positive cells (Figure 3.2 A).   The MHC class II and CD11c expression 
distinguished the cells as myeloid origin. From the gated population, further analysis 
was examined for the expression of CD40, CD80 and CD11b (Figure 3.2 B and C). 
The LPS increased the percentage of CD40
+ DCs and the mean fluorescence intensity 
of the CD80
+ DC.   The increased mean fluorescence intensity of CD80 indicated an 
increase cell surface expression of the molecule. The expression of both CD40 and 
CD80 indicate that the immature mDCs were able to activate and mature.  
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Figure 3.2. The phenotype analysis of two BMDC cultures after 8 day culture period. 1 
not simulated with LPS (left) and1 stimulated with LPS (right). (A) The expression of 
MHC class II and CD11c.  (B) The CD80 and CD11b expression of gated population. 
The CD80 -/ CD11b – (lower left), CD80 -/ CD11b + (lower right), CD80 +/ CD11b + 
(upper right) and CD80 +/ CD11b – (upper left). (C) The CD40 and CD11b expression 
of gated population. The CD40 -/ CD11b – (lower left), CD40 -/ CD11b + (lower right), 
CD40 +/ CD11b + (upper right) and CD40 +/ CD11b – (upper left) 
A 
B 
C 
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3.4.2 Optimisation of Vero Cell Harvesting Methods 
Two cell harvesting techniques for adherent cells, trypsinisation and cell scraping were 
compared to determine the best method to preserve cell viability for flow cytometry.  
The techniques were analysed for their forward and side scatter by flow cytometry to 
determine the impacts on cell dynamics.  Figure 3.3 shows the forward and side light 
scatter profiles obtained by flow cytometry for the cells obtained by each method as 
indicators of cell size and granularity respectively. Both methods were successful in 
harvesting the Vero cells however there was variation between the methods in terms of 
scatter profiles produced. The trypsinised cells produced a more defined population of 
cells that were consistent in size and internal complexity along with a reduced amount 
of cell debris (Figure 3.3, left panel). The cells harvested by the scraper produced the 
opposite: a more heterogenous population with an increase in cell debris, reflecting that 
damaging  nature  of  this  harvesting  method.  In  conclusion,  the  harvesting  method 
impacts  the  forward  and  side  scatter  characteristics  of  normal  Vero  cells  and 
trypsinisation was chosen as the optimum harvesting method to preserve cell viability 
and structure.  
 
 
Figure 3.3: The comparison of Vero harvesting methods. The forward scatter indicates the size 
of the cell. The side scatter indicates the complexity of the cell. The trypsinized Vero cells show 
a defined population with similar characteristics. The scraped Vero cells show a less defined 
population with more variation in cellular characteristics. 
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3.4.3 Optimisation of Camptothecin Concentrations 
CPT was chosen as an apoptotic inducing compound to act as a positive apoptosis 
control in subsequent experiments. Different concentrations had been used with Vero 
cells  throughout  the  literature.  Two  concentrations  were  chosen  from  two  papers 
(Hofmann  et  al.  1999;  Brown  et  al.  2009),  with  a  third  as  a  middle  point.  The 
expression  of  Annexin  V and  7−AAD  (as  a  live/dead  marker)  binding  at  each 
concentration after 24 h incubation was compared (Figure 3.4). All three had an impact 
on cell viability.  The 14.5 µ mol/L CPT provided a higher percentage of late and early 
apoptotic cells compared to the 1 and 5 µ mol/L experiments and was therefore was 
chosen for further analysis.  
 
 
 
Figure  3.4:  Comparison  of  CPT  concentrations  on  apoptosis  induction.  (A)  An  example  of  the 
1 µ mol/L CPT FSC/SSC plot showing the selection gate which was used on all samples. (B)  The 
basic layout for the expression of Annexin V, an apoptotic marker and 7-AAD, a necrotic marker, 
showing the apoptotic, necrotic and live cell quadrants.   (C) Different CPT concentration-treated 
Vero cells analysed for PE-conjugated Annexin V and 7-AAD binding after 24 h incubation.  Page | 55 
3.4.4 FLICA and Live/Dead Stain Optimisations  
3.4.4.1 FLICA 
To determine if the FLICA working concentration had an impact on the fluorescence 
and percentages of apoptotic cells, different working concentrations were prepared and 
tested. (Figure 3.5 A).The FLICA positive population over all concentrations showed 
little change in the percentage of cells present: the 10× population presented 4.22 % of 
cells while 15×, 20× and 30× all presented over 5% of cells (gated cells in Figure 3.5 
A). However, the degree of separation between the live (FLICA- negative) population 
and the FLICA positive cells (gated) appeared to vary over the concentrations. The 15× 
and 20× populations were situated in a similar position, while the live population of the 
30× was closer to the FLICA positive box.  Due to these major changes between the 
concentrations,  15×  working  FLICA  concentration  was  used  for  FLICA  staining, 
allowing for one kit per cell type to be used during the time course analysis.  
 
3.4.4.2 Live/Dead Viability Stain 
Different  Live/Dead  viability  stain  volumes  were  tested  in  order  to  optimise  the 
intensity of fluorescence. As shown in Figure 3.5 B, the overall fluorescence of the live 
and  dead  populations  decrease  with  the  reduction  in  volume  used,  without  cell 
percentages  varying  greatly.  To reduce the impact  of the fluorescence on the two 
populations without impacting the live cells, the 0.1 µL of live/dead viability stain to 
500 µL of cell suspension was chosen for the time course analysis.  
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3.4.4.3 Annexin V Stain 
Due  to  no  issues  with  the  Annexin  V  fluorescence  intensity  or  stain  viability 
difficulties, the stain was used as per the manufacturers’ instructions for the project. 
Figure 3.5:  Working concentrations of FITC- conjugated FLICA and APC- conjugated Live/Dead.  
(A) The different working concentrations of FLICA on single stained cells exposed to 14.5µ mol/L 
CPT for 24 h. The gated population represents FLICA-positive cells. (B) The different volumes of 
Live/Dead on single stained mixed population cells. The mixed population consisted of a 
combination of healthy and liquid nitrogen exposed Vero cells. The dead cells (top population) 
fluorescence is higher than the live cells (bottom population) due to the staining of intracellular 
amines as well as the plasma membrane.   Page | 57 
3.4.5 Analysis of Apoptosis in Vero Cells 
Four time points were chosen for the Vero cell apoptosis analysis by flow cytometry 
flowing RRV-NE and RRV-SW inoculation. These time points were 8, 24, 48 and 72 h 
post inoculation.   
 
3.4.5.1 FLICA and Live/Dead Stains 
Mock (negative control), CPT (positive control), RRV–NE and RRV–SW samples were 
analysed with FLICA and Live/Dead stain expression at the individual time points in 
order to detect caspase activation as a measure of cell viability (Figure 3.6).   
 
For both the mock and CPT controls, there was a slight increase in the proportion of 
early  apoptotic  cells  from  8  h  to  72  h,  however  the  percentage  of  cells  remained 
relatively low (Figure 3.6, upper and second rows, lower right quadrants). For late 
apoptotic cells, again the percentage of cells in the mock control increased slightly over 
the time course, while the CPT induced significant changes become after 48 h with a 
further increase by 72 h (Figure 3.6 upper and second rows, upper right quadrants).   
The two RRV isolates were similar to the mock and CPT controls at 8 h and 24 h, 
however a marked increase in the percentage of both  early and late apoptotic cells was 
observed at 48 h, with further increased at 72 h (Figure 3.6, third and fourth rows).  
 
A summary of the above data is shown in Figure 3.7. There was little variation in the 
percentage of late apoptotic cells and dead cells induced by the two RRV isolates in 
Vero cells over the time course of the study however both isolates induced apoptosis 
and cell death at a faster rate than the CPT control over the 24 h to 72 h period (Figure 
3.7 A and B). For early apoptosis both RRV strains induced a peaked response at 48 h  
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that was markedly higher than the CPT control, but in this case the RRV-NE isolate 
induced a higher percentage of early apoptotic cells when compared to the RRV-SW 
isolated at the peak of the response (Figure 3.7 C).  
 
 
Figure  3.6.  RRV-infected  Vero  cells  undergo  apoptosis.  FITC-conjugated  FLICA  and  APC-
conjugated  Live/Dead  of  RRV-infected  (NE  and  SW),  mock–infected  (uninfected)  and  CPT-
inoculated (apoptosis induced). The percentages represent the proportion of non-apoptotic (lower 
left), early apoptotic (lower right), late apoptotic (upper right) and necrotic cells (upper left) after 8, 
24, 48 and 72 h post-inoculation.  Data represents 1 experiment (n= 16).  
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Figure 3.7. Percentages of (A) late apoptotic, (B) total cell death and (C) early apoptotic 
cells over 8-72h for the two RRV isolates (NE and SW), mock infected and CPT inoculated. 
Data represents 1 experiment (n= 16). 
A  
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3.4.5.2 Annexin V and Live/Dead Stains 
Mock (negative control), CPT (positive control), RRV–NE and RRV–SW isolates were 
analysed at the same time points as above and apoptosis assessed by flow cytometry 
using  the  Annexin  V  and  Live/Dead  stains  as  a  comparison  to  the  FLICA  stain 
described above, in order to determine if any membrane polarity apoptotic changes were 
apparent.  Using  this  approach,  no  considerable  induction  of  early  apoptosis  was 
observed in any of the treatments (Figure 3.8, lower right quadrants).  However, a 
substantial proportion of late apoptotic cells were observed in the CPT treated and the 
RRV-infected cells, which increased with time and were significantly increased above 
the mock controls (Figure 3.8, upper right quadrants). 
 
A  summary  of  the  flow  cytometry  data  is  shown  in  Figure  3.9.  As  no  significant 
number of early apoptotic cells was observed, only data for late apoptosis and cell death 
are shown. The percentage of late apoptotic cells in the mock-infected cultures showed 
a slight increase over time but maintained below CPT values, which increased from 
24 h to 48 h (Figure 3.9 A). The percentage of dead cells showed a similar trend for the 
mock and CPT controls, while the percentage of RRV-induced late apoptotic and dead 
cells  peaked  higher  than  both  controls  over  time,  with  a  rapid  increase  after  24  h 
(Figure 3.9 A and B).  
 
However, there was  some variation between the two RRV isolates in terms  of late 
apoptosis induction. The RRV-SW isolate showed a plateau effect over the 24 h period 
from 48 h to 72 h, while the RRV-NE isolate continued to increase (Figure 3.9A).  
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However, no variation between the two isolates in the percentage of dead cells was 
observed (Figure 3.9 B).  
Figure 3.8. RRV-infected Vero cells undergo membrane polarity change.  PE-conjugated annexin V 
and APC-conjugated Live/Dead of RRV-infected (NE and SW), mock–infected (uninfected) and CPT-
inoculated (apoptosis induced). The percentages represent the proportion of non-apoptotic (lower left), 
early apoptotic (lower right), late apoptotic (upper right) and necrotic cells (upper left) after 8, 24, 48 
and 72 h post-inoculation.  Data represents 1 experiment (n= 16).  
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Figure 3.9. Percentages of (A) late apoptotic cells and (B) combined Vero cell death 
over 8-72  h  for  the  two  RRV  isolates  (NE  and  SW),  mock  infected  and  CPT 
inoculated. Data represents 1 experiment (n= 16).  
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3.4.6 Analysis of Apoptosis in BMDCs 
Due to limited cell numbers, two time points were chosen based on the Vero cell results 
for the BMDCs apoptosis analysis by flow cytometry. These time points were 24 h and 
48 h post inoculation. Again, due to limited availability of cells, no CPT control was 
used in the BMDC analysis due to time and cell yield restrictions. 
 
3.4.6.1 FLICA and Live/Dead Stains 
Mock, (negative control), RRV–NE and RRV–SW isolates were analysed with FLICA 
and Live/Dead stain to compare cell viability at each time point (Figure 3.10).  All 
samples had weaker FLICA signals than expected based on the Vero results, with the 
clear variation in late apoptotic and dead cell numbers between the mock and RRV-
infected cells at the 24 h time point.  
 
The above data is summarised in Figure 3.11. The percentage of late apoptotic cells 
induced by each treatment did not differ considerably over the two time points (Figure 
3.11 A). The RRV-NE isolate induced the highest degree of late apoptosis compared to 
both the mock control and RRV-SW isolate at both time points.  Further, the RRV-SW 
strain induced lower levels of apoptosis than the background levels observed in the 
mock control (Figure 3.11A). Further analysis of the combined dead cell quadrants 
(late  apoptotic  and  necrotic  –  upper  left  quadrants  in  Figure  3.10)  was  also 
performed. Both isolates of RRV induced a higher percentage of cell death compared to 
the mock at both time points (Figure 3.11 B). At 24 h the RRV-SW isolate had a higher 
percentage of cell death compared to the RRV-NE isolate. At 48 h, the reverse was 
observed, with the RRV-NE higher than RRV-SW. In contrast, the percentage of non- 
Page | 64 
apoptotic  cells  did  not  vary  greatly  (Figure  3.11  C).  While  the  numbers  of  non-
apoptotic cells in the RRV-NE infected cultures did not to change between time points, 
RRV- SW at 24 h produced a low percentage of non-apoptotic cells, however at 48 h 
was similar to the mock and RRV-NE.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.10.  RRV-infected  BMDCs  undergo  cell  death.  FITC-conjugated  FLICA  and 
APC-conjugated  Live/dead  staining  of  RRV-infected  (NE  and  SW),  mock–infected 
(uninfected). The percentages represent the proportions of non-apoptotic (lower left), early 
apoptotic (lower right), late apoptotic (upper right) and necrotic cells (upper left) after 24 h 
and 48 h post-inoculation. Data represents 1 experiment (n= 6).  
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Figure 3.11. Percentages of (A) late apoptotic cells, (B) combined dead cells and (C) 
non-apoptotic BMDCs at 24 h and 48 h post infection of the two RRV isolates (NE 
and SW) and mock infected. Data represents 1 experiment (n= 6). 
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3.4.6.2 Annexin V and Live/Dead Stains 
Mock,  RRV–NE  and  RRV–SW  isolates  were  analysed  for  changes  in  membrane 
polarity induced in BMDC as based on Annexin-V expression at the 24 h and 48 h time 
points.  All  samples  showed  prominent  staining  with  the  Annexin  V  and  Live/Dead 
markers, with cells present in all four quadrants (Figure 3.12). 
 
As summarised in Figure 3.13 A, the mock had a lower percentage of early apoptotic 
cells compared to the RRV-NE and RRV-SW isolates, at both time points. The RRV-
SW sample at both time points produced a higher percentage of cells compared to the 
RRV-NE. By 48 h, the percentage of cells in all quadrants for all samples increased. As 
illustrated in Figure 3.13 B, with the percentage of late apoptotic cells was higher in 
both RRV-NE and RRV-SW cultures when compared to the mock control at 24 h, and 
the RRV-SW isolate produced a higher number of late apoptotic cells compared to the 
RRV-NE isolate, which did not vary greatly from 24 h value.  Figure 3.13 C shows the 
variation in overall cell death, with similar results to Figure 3.13 B for all samples. The 
percentage of non-apoptotic cells did not vary greatly between the samples, with the 
variation only noticeable at 24 h. Both RRV isolates produce a lower percentage of non-
apoptotic cells compared to the mock. In BMDCs, RRV induces an apoptotic death 
response with some variation between isolates. 
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Figure 3.12. RRV-infected BMDCs undergo membrane polarity change. PE-conjugated Annexin V 
and  APC-conjugated  Live/Dead  staining  of  RRV-infected  (NE  and  SW),  mock–infected 
(uninfected). The percentages represent the proportions of non-apoptotic (lower left), early apoptotic 
(lower right), late apoptotic (upper right) and necrotic cells (upper left) quadrants 24 h and 48 h 
post-inoculation.  Data represents 1 experiment (n= 6). 
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Figure 3.13. Percentages of (A) early apoptotic, (B) late apoptotic and (C) combined 
dead BMDCs at 24 h and 48 h post inoculation of the two RRV isolates (NE and SW) 
and mock infected. Data represents 1 experiment (n= 6).  
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Chapter 4: Discussion 
The purpose of this study was to determine if RRV infection would induce apoptosis 
differently in mammalian cell types from an immune and non-immune origin.   This 
was the first study to show potential differences between the RRV phenotypes and the 
induction of apoptosis in dendritic cells.  The overall aim of this study was to examine 
the kinetic expression of apoptotic and cell death markers in Vero cells and in BMDCs 
following infection with phenotypically distinct strains of RRV.  
 
4.1 Cell Culture Models 
The  Vero  cell  line  was  selected  as  the  non-immune  cell  type.    This  cell  line  is 
commonly used for the in vitro propagation of alphaviruses (Levine et al. 1993; Griffin 
2001) and infection presents as lytic CPE within 24 h (Raghow et al. 1973).  Initial 
Vero cell stocks from Dean Pemberton, Murdoch University, failed to produce a lytic 
response after inoculation with RRV. The reason for the failure of the RRV to produce 
CPE is unknown with further analysis needed on these stocks to confirm that the stocks 
are  truly  Vero  cells  and  verification  of  RRV-infection  was  present.  However,  an 
alternative source of Vero cells supported lytic RRV infection and displayed expected 
CPE. If the original Vero cells are truly resistant to infection with RRV, further analysis 
is warranted, to determine any differences between the two sources of Vero cells. Such 
experiments  would  help  dissect  the  mechanisms  of  RRV  attachment,  entry  and 
replication in vertebrate host cells. 
 
Initial attempts to complete plaque assays proved unsuccessful, even though they have 
been used to determine RRV titre previously (Lidbury and Mahalingam 2000; Lidbury  
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et al. 2011). The possible reason for the failure was the inability of the neutral red dye 
to penetrate the agar overlay and further experimentation is required to optimise the 
plaque assay for RRV in our laboratory. As RRV is a cytopathic virus, TCID50 assays 
were performed to determine virus concentration. This assay has been validated and 
reproducibly used technique used for RRV by others (Kistner et al. 2007) and also for 
other togaviruses (Hofmann et al. 1999).  
 
BMDCs were selected as the immune cell type. These DCs yield a higher number of 
cells compared to peripheral blood DCs and Langerhan’s cells (Lutz et al. 1999). The 
DCs collected for the study presented with a lower than expected cell yield; 1× 10
6 
cells/mL,  after 8 days of culture with the minimum expected concentration of cells 
being 5 × 10
6 per mL (Lutz et al. 1999). The exact reason for the reduced cell yield is 
unknown, but may include a reduced yield of cells collection and seeding after bone 
marrow harvest or a deficiency with the growth factor, GM-CSF (Lardon et al. 1997; 
Lutz et al. 1999; Banchereau et al. 2000). BMDCs have been used in RRV studies 
previously (Shabman et al. 2007; Shabman et al. 2008). Due to time limitations no 
infection confirmation was done in this study.   
 
In vitro studies involving RRV and DCs have not investigated on the impact of RRV 
infection  on  DC  survival  and  the  potential  implications  of  immunosuppression. 
Previous  in  vitro  studies  involving  RRV  and  DCs  have  targeted  the  type  I  IFN 
responses towards virus derived from mosquito and mammalian cell culture (Shabman 
et al. 2007; Shabman et al. 2008).  Therefore, this is the first study to focus on the 
impact of RRV on DC survival. 
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4.2 Analysis of Preliminary Apoptosis Results 
FLICA,  Annexin  V  and  Live/Dead  staining  was  used  to  study  the  impact  of  RRV 
infection in vitro and the differences between genotypes, since apoptosis is believed to 
be induced in alphavirus lytic infection (Levine et al. 1993; Strauss and Strauss 1994).  
RRV produced an apoptotic death response in both Vero cells and BMDCs with some 
variation between the two isolates.    
 
4.2.1 Analysis of Apoptosis in Vero Cells 
The  results  in  the  Vero  cells  experiments  determined  that  the  cell  death  observed 
following inoculation with RRV was largely due to RRV, as background apoptosis of 
the uninfected mock was small. The rate of RRV-induced apoptosis was faster than the 
positive CPT control over time (Figure 3.7 A and 3.9 A).   These data may suggest that 
the induction mechanism of RRV-apoptosis may be independent of DNA replication, 
and  apoptosis  may  correlate  with  viral  replication.    Overall,  the  data  of 
phosphatidylserine  exposure  and  caspase  activation  in  RRV  infected  cells,  correlate 
with  other studies  that have observed apoptotic features  in  alphavirus  infected  cells 
indicating that RRV can induce apoptosis in cells (Levine et al. 1993).   
 
While  there  was  no  substantial  difference  overall  between  the  two  isolates,  subtle 
differences in the percentage of early and late apoptotic cells were evident and may 
have important virulence implications. For example, the SW isolate induced a more 
rapid onset of late apoptosis than NE over the Annexin V time course (Figure 3.9 A). 
Although  the  percentage  of  cells  affected  was  higher  in  the  NE  isolate  over  time 
(Figure 3.7 A and 3.9 A).  Furthermore, the SW induced a lower peak percentage of 
early apoptotic cells than the NE virus strain (Figure 3.7 C).   These data may suggest  
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that the SW isolate could  be more virulent,  inducing  apoptosis  earlier than the NE 
isolate. In vitro studies by Prow (2006) observed no significant differences between the 
strains in Vero cells. 
 
FLICA  and  Annexin  V  are  widely  accepted  apoptotic  markers  for  flow  cytometry 
analysis (Vermes et al. 2000). In all the apoptosis experiments using Vero cells and 
BMDCs in this thesis both markers produced positive populations; however variation 
did occur between the two markers. An example is the difference in the percentage of 
early  apoptotic  signals  in  Vero  cells  (Figure  3.6  and  3.9,  lower  right  quadrant).  
Apoptosis can be a fast process and it can be difficult to distinguish between cells that 
have completed apoptosis and those that are about to commence apoptosis (Gilmore and 
Streuli  2002).  FLICA  has  a  broad  detection  window  compared  to  other  apoptotic 
markers  including  Annexin  V  which  could  explain  the  variation  (Pozarowski  et  al. 
2003b). More likely, the impact of formaldehyde fixation and harvesting may explain 
some of these results.  FLICA is an irreversible, stable, intracellular marker that can 
withstand  cell  fixation  (Smolewski  et  al.  2002),  while  Annexin  V  is  a  reversible, 
extracellular based marker (Koopman et al. 1994; Brumatti et al. 2008).  The majority 
of authors advise against fixing Annexin V stained cells due to its reversible nature, 
leading to either a degraded signal or non-specific Annexin V staining (Brumatti et al. 
2008).  Staining  with  Annexin  V  is  not  advised  for  adherent  cells  harvested  with 
routinely  applied  techniques  such  as  trypsinization  or  cell  scraper,  as  membrane 
changes can be induced, exposing phosphatidylserine (van Engeland et al. 1996; van 
Engeland et al. 1998).  
  
Page | 73 
An alternative method for Annexin V staining of adherent cells was developed by van 
Engeland (1996), with labelling with Annexin V occurring prior to quantitative harvest. 
Alternatively an enzyme known as Accutase has been used successful in Annexin V 
analysis of adherent cells and this could be used in the future as an substitute for trypsin 
(Park et al. 2007; Weigert et al. 2007; Wang et al. 2010) allowing the multi-parameter 
analysis of one flask.  
 
In  addition,  caution  must  be  taken  with  the  FLICA  staining.  The  reason  for  the 
inconsistent  staining  in  this  study  is  unknown.  FLICA  has  been  compared  to  other 
methods including TUNEL (TdT-mediated dUTP Nick End Labelling) (Bedner et al. 
2000; Pozarowski et al. 2003b) and immunocytochemistry (Pozarowski et al. 2003a) 
demonstrating that it is a proven marker of apoptosis. However, there have been reports 
of non-specific caspase binding by FLICA (Pozarowski et al. 2003b; Darzynkiewicz 
and  Pozarowski  2007).  Due  to  the  potential  non-specific  binding,  FLICA  may  be 
involved with other cell constituents which may vary between cell types and so further 
analysis  is  required    to  confirm  in  FLICA  as  an  appropriate  and  reliable  apoptosis 
marker  (Pozarowski  et  al.  2003b).  Several  other  methods  of  apoptosis  analysis 
including  TUNEL,  immunohistochemistry  and  fluorescence  microscopy 
(Darzynkiewicz et al. 1992; Vermes et al. 2000) could be combined with the apoptotic 
markers used in this study to validate the observations. 
 
4.2.2 Analysis of Apoptosis in BMDCs 
Results from the BMDCs studies found that the RRV induced a strong pro-apoptotic 
response in BMDCs. This conclusion was based on the data which demonstrated that 
uninfected cells showed a low level of apoptosis with high levels of non-apoptotic cells  
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in the population (Figure 3.11 and 3.13).  Furthermore RRV induced a faster and more 
aggressive  pro-apoptotic  response  in  BMDCs  compared  to  Vero  cells  at  24  h  after 
inoculation.  Aaskov  et  al.  (1983) suggested that  RRV may target  APCs,  like DCs 
before  the  cell  can  properly  fulfil  its  function  to  mount  an  immune  response. 
Preliminarily data suggests that RRV could target DCs to induce apoptosis early in 
infection  and  may  impact  DC  function.    Collectively  this  could  be  important  in 
understanding the pathogenesis and virulence of the RRV.  
   
 Results from the BMDCs study found that the SW isolate was more aggressive in DCs 
compared to the NE isolate. This conclusion was based on data which showed the SW 
isolate  to  have  the  higher  apoptotic  response  at  24  h  (Figure  3.13  A  and  B).   
Furthermore, the percentage of total cell death at 24 h was found to be the highest with 
the SW isolate (Figure 3.11 B and 3.13 C).    At the 48 h time point, the decline in 
apoptotic cells for the SW isolate may be due to the engulfment of apoptotic cells by 
bystander DCs and macrophages present in the culture.  Collectively, these data may 
suggest that the SW isolate could be more virulent and have a negative impact on the 
immune  response.  A  study    on  SW  and  NE  phenotyped  isolates  showed  similar 
differences using  in vivo suckling mouse models, with the SW presenting as the more 
virulent  virus  strain  (Prow  2006).  Observations  of  RRV  isolates  from  different 
geographical regions that differ in the level of virulence have been noted in mouse and 
mosquito models (Kerr et al. 1992; Lindsay et al. 1993; Russell 2002).  In relation to 
other alphaviruses, different strains of SINV that differ in virulence have been observed 
to have an impact on whether an infection may cause apoptosis or not (Appel et al. 
2000).     
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Measles,  CMV  and  LCMV  all  infect  DCs  and  interfere  with  the  DCs  specialized 
functions to enhance their own pathogenesis (Carbone and Heath 2003; Cunningham et 
al. 2010). The inhibition of cytokine secretion (IL-12), apoptosis,  limited maturation 
and expression of MHC Class I and II molecules lead to immunosuppression through 
the  failure  to  stimulate  proliferation  of  naïve  T  cells  (Fugier-Vivier  et  al.  1997; 
Andrews et al. 2001; de Witte et al. 2006). In measles infection the Th responses shift 
from Th1, cell-mediated to Th2, humoral-mediated leading to insufficient elimination of 
the virus. The exact  mechanism for this  is  unknown,  but the inhibition of  IL-12 is 
suspected to be involved (Fugier-Vivier et al. 1997).  
 
The impacts of interference with DC function results in an impaired capacity to initiate 
a specific immune response towards the virus. Figure 4.1 depicts the life cycle of a DC. 
If  a  virus  infects  an  immature  DC  and  suppresses  its  ability  to  mature  and  secrete 
stimulatory cytokines, activation of the viral-specific response will be impaired. The 
failure to activate Th1 cells will impact the Tc response, as Tc generally needs Th1 
assistance  for  activation  and  results  in  an  ineffectual  cell-mediated  response 
(Banchereau et al. 2000).  Differences in the Tc responses to viruses injected into the 
skin  have been observed which suggest  that cytopathic viruses  like Herpes  simplex 
virus -1 may hamper the ability of skin DCs to prime virus specific Tc responses (Allan 
et al. 2003; Merad et al. 2008). By negatively impacting DCs, viruses have the potential 
to enhance their pathogenesis and establish a long-term persistence.    
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The potential implications of RRV-induced apoptosis in cells from an immune origin 
could support the idea that the persistence of RRV may be the result of ineffectual 
clearance by impaired immune responses (Linn et al. 1998; Rulli et al. 2005).   If RRV 
interferes with DC in an immunosuppressive form it may help explain the differences 
between  predominant  CD4
+  T  cells  in  mononuclear  synovial  effusions  of  chronic 
RRVD patients and the almost exclusive CD8
+ T cells present in the skin tissue of 
RRVD  patients  with  early  and  complete  recoveries  (Fraser  et  al.  1983;  Fraser  and 
Becker 1984).  The variation between isolates may help explain the differences in the 
severity and duration of RRVD across Australia 
 
 
Figure 4.1 The life cycle of dendritic cells (DC).  Immature DCs enter the 
tissues. After antigen capture, the immature DCs migrate to the local lymph 
node  where,  after  maturation,  present  the  antigen  to  T  cells  via  MHC 
molecular. This leads to the activation and co-ordination of anti-viral T cell 
and antibody responses [Figure from (Banchereau et al. 2000)].  
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The potential implications of these results on the DC-T cell interaction may explain the 
differences in T cell responses in patients, persistence of the virus and differences in the 
strains 
 
 Studies  on  RRVD  patients  have  observed  a  correlation  between  the  type  T  cell 
response and the duration/ severity of the disease (Harley et al. 2001).   Patients with 
chronic RRVD, have a predominance of CD4
+ T cells in their mononuclear synovial 
effusions, contrasts from these observations, it suggests that individuals who develop 
chronic RRVD fail to generate RRV-specific CD8
+ T cell response.   Other studies into 
alphavirus-specific Tc observed that the cells were capable, in vitro, to eliminate RRV 
from persistently infected macrophages (Linn et al. 1998) and their activity correlated 
with clearance of viremia from the peripheral blood in mice models (Peck et al. 1979; 
Blackman and Morris 1984). 
 
4.3 Future Directions 
Even though this study provides preliminary evidence of RRV-induced apoptosis in 
DCs with notable differences between the two virus isolates it is far from conclusive. It 
is vital that research into the effects of RRV infection on apoptosis regulation in DCs is 
further developed. The impact of RRV on DC function requires confirmation. Further 
studies could employ an extended time course to determine if cell viability is alters prior 
to 24 h in BMDCs as well as to determine total cell numbers instead of the proportional 
percentage of the populations. It would be advantageous to complete further analysis on 
the different DC subtypes, in particular pDCs and skin DCs to study the impact on DC 
functions through in vivo and in vitro models, in particular DC – T cell interactions. 
Extending the number and genomic sequencing of isolates from different phenotypic  
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virus groups may also provide knowledge of the differences within circulating RRV 
strains.    These  types  of  investigations  may  lead  to  the  development  of  specific 
immunotherapeutic targets for clinical use. 
 
4.3 Conclusions 
In this study apoptotic and cell death markers were used to investigate the impact of 
RRV infection in Vero cells and BMDCs using two different RRV isolates. The data 
obtained indicated that RRV induced apoptosis in BMDCs faster than in Vero cells, 
potentially enhancing virus pathogenesis. The potential implications of RRV-induced 
apoptosis in cells from an immune origin could support the idea that the persistence of 
RRV may be the result of ineffectual clearance by impaired immune responses (Linn et 
al. 1998; Rulli et al. 2005). 
  
Furthermore in BMDCs, the two isolates had different impacts on cell death; with the 
SW isolate inducing a faster response compared to the NE isolate, indicating a possible 
difference in virulence.   This possible difference may help to explain the variation in 
the severity and duration of human clinical symptoms, linking the symptoms to the 
strains.  
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